Abstract
As a degenerative disease, osteoarthritis (OA) is critically influenced by inflammation and extracellular matrix (ECM) degradation in the repair of articular cartilage. Though the in-situ hydrogel could alleviate joint pain with high patient compliance, the synergetic management of the pathological progression of osteoarthritis is limited. Herein, a microenvironment-responsive chemo-electroactive hydrogel is designed by integrating asymmetric magnesium hydrogen generators (MHG) and black phosphorus nanosheets (BPNS) within a biomimetic double-network matrix (PHO) for cartilage repair. The MHG and BPNS couple to form a micro-galvanic cell, where MHG provides electrons and BPNS acts as a low-impedance heterogeneous cathode, establishing a stable microcurrent field. The biomimetic double-network not only provides PHO-MHG@BP with excellent injectability and self-healing ability, but also triggers intelligent release of H2 and Mg2+ under the acidic conditions typical of osteoarthritis. This facilitates scavenging ROS and restoring the inflammatory microenvironment. Simultaneously, the PHO-MHG@BP hydrogel facilitates localized microcurrent transmission through an in situ micro-galvanic cell reaction, achieving long-term bioelectrical regulation for chondrocyte proliferation via the CaMKII signaling cascade. These results demonstrate that the chemo-electroactive hydrogel not only restores redox and bioelectrical homeostasis but also modulates the OA microenvironment, providing a comprehensive therapeutic strategy for osteoarthritis.
Keywords: Chemo-electroactive hydrogel, Mg-based hydrogen generator, ROS scavenging, Anti-inflammation, Osteoarthritis therapy
Graphical abstract

Highlights
-
•
·An injectable, pH-responsive chemo-electroactive hydrogel is fabricated by integrating asymmetric Mg-based hydrogen generators and black phosphorus nanosheets.
-
•
·The system synergizes antioxidant hydrogen release with a conductive network to restore redox and bioelectrical homeostasis.
-
•
·ROS scavenging resensitizes L-VGCCs, enabling microcurrent-induced Ca2+ influx to activate the CaMKII pathway for cartilage regeneration.
-
•
·The hydrogel effectively inhibits cartilage degradation, suppresses synovial inflammation, and preserves subchondral bone microstructure in vivo.
1. Introduction
The repair and regeneration of articular cartilage remains a significant clinical challenge. This is mainly due to the limited intrinsic regenerative ability of cartilage and the highly complex inflammatory microenvironment [1,2]. While mechanical wear of bone joints exacerbates inflammation, making cartilage regeneration difficult. As the most prevalent degenerative joint disease, osteoarthritis (OA) is characterized by the progressive degradation and loss of articular cartilage as its core pathological features [3], accompanied by aberrant subchondral bone remodeling, osteophyte formation, and chronic inflammation of the synovium [[4], [5], [6]]. These multifaceted pathological alterations exacerbate joint degeneration and impede effective cartilage regeneration. Contemporary clinical interventions for OA include pharmaceuticals (e.g., nonsteroidal anti-inflammatory drugs), physical therapy, and joint replacement surgery. However, these strategies primarily target the suppression of inflammation and pain relief, rather than the fundamental reconstruction of tissue. Challenges like systemic side effects of drugs and risk of postoperative complications hinder their adoption [7]. Recently, intra-articular injections (e.g., hyaluronic acid) have been considered as a viable alternative for local therapy, capable of increasing local drug concentration while minimizing systemic toxicity. However, conventional intra-articular delivery platforms, such as nanocarriers, liposomes, hydrogel microspheres, and exosome-like vesicles face significant translational limitations. Firstly, due to their discrete micro/nanoscale dimensions, these fluidic particulate systems are highly susceptible to rapid clearance via continuous synovial fluid turnover and lymphatic drainage. Secondly, they are prone to rapid phagocytosis by synovial macrophages, which not only causes the premature degradation of active agents but also risks triggering off-target inflammatory responses. Thirdly, these dispersed systems typically suffer from initial burst release profiles, failing to maintain effective therapeutic concentrations over prolonged periods [[8], [9], [10], [11]]. In contrast, macroscopic in situ forming injectable hydrogels overcome these pharmacokinetic limitations. By undergoing a rapid sol-gel transition, they form a stable bulk 3D network that effectively resists fluidic washout, restricts premature macrophage engulfment, and securely anchors the therapeutic components within the joint space, thereby ensuring the continuous and sustained release of chemo-electroactive signals [12,13]. Therefore, there is an urgent need to develop a novel therapeutic system capable of in situ retention and multi-functional regulation to provide comprehensive intervention against the complex pathology of OA [[14], [15], [16]].
Electrical stimulation (ES) has been verified as a promising external intervention to stimulate stem cells to differentiate into chondrocytes for the regeneration of cartilage tissues [17]. In the complex pathology of OA, the dysregulation of the bioelectrical microenvironment represents an often overlooked yet critical barrier to tissue regeneration [18]. In healthy joints, movement-generated microcurrents and local charge distributions play crucial roles in maintaining cartilage homeostasis, cellular function, and reparative responses [17,[19], [20], [21], [22]]. In OA, however, progressive cartilage degeneration and the consequent loss of ECM components inevitably disrupt the tissue's intrinsic biophysical properties, macroscopically manifesting as a significant elevation in local electrical impedance. This creates a resistive “physical barrier” that severely impedes the transmission of endogenous regenerative bioelectrical signals. Because of this barrier, simply implanting passive conductive materials is insufficient to restore the local bioelectrical network. Furthermore, most conductive materials (e.g., conductive polymers, metal nanoparticles, and carbon-based materials) exhibit slow in vivo degradation, which may trigger immune responses or even impede tissue regeneration [[23], [24], [25]]. Therefore, there is a compelling need to develop an electrochemical material capable of actively generating localized microcurrents to overcome this impedance barrier, while possessing excellent biocompatibility and biodegradability, thereby driving cellular regeneration and cartilage repair. The electrochemical properties of Mg-based materials offer intrinsic advantages in this context. The corrosion behavior of Janus Mg particles (Mg → Mg2+ + 2e−; 2H2O + 2e− → H2 + 2OH−) in a physiological environment is fundamentally an electron-releasing electrochemical process, accompanied by the generation of self-powered microcurrents and H2 release [26,27]. This process not only generates continuous electrical stimulation for bioelectrical signal transduction but also releases hydrogen gas (H2) with antioxidant properties, which holds the potential to provide autonomous electrical stimulation and regulate the microenvironment necessary for cartilage repair.
Oxidative stress is a well-established core pathological mechanism driving OA progression, directly causing matrix degradation, chondrocyte apoptosis, and the amplification of inflammatory cascades. Consequently, efficiently scavenging reactive oxygen species (ROS) is fundamentally paramount to halt pathological tissue degeneration. However, while resolving oxidative stress slows disease progression, active biophysical interventions, such as microcurrent stimulation, are concurrently required to drive extracellular matrix reconstruction and cartilage regeneration [[28], [29], [30]]. Interestingly, mitigating oxidative stress provides an additional synergistic benefit: it protects cell membrane ion channel proteins from oxidative modification, thereby preserving cellular electrophysiological sensitivity and maximizing the regenerative efficacy of the electrical stimulation. The integration of Mg-based materials and black phosphorus nanosheets (BPNS) intrinsically meets these synergistic therapeutic requirements. H2 released during Mg corrosion serves as an efficient ROS scavenger, exhibiting excellent biocompatibility and antioxidant activity [[31], [32], [33]]. Furthermore, black phosphorus nanosheets (BPNS), by virtue of their high carrier mobility, can act as an efficient heterogeneous cathode and establish low-impedance electron channels for microcurrent transmission, while uniformly possessing intrinsic antioxidant properties [[33], [34], [35]]. Hence, the combined antioxidant and electrical stimulation effects induced by Mg and BPNS may provide a prospective strategy for OA therapy.
Herein, we demonstrated a microenvironment-responsive and injectable chemo-electroactive hydrogel system (PHO-MHG@BP) for efficient therapy for OA by tackling electrophysiological dysregulation and oxidative stress. By crosslinking porcine acellular dermal matrix (PADM), hydroxypropyl chitosan (HS), and oxidized hyaluronic acid (OHA), the biomimetic double-network matrix (PHO) was formed as a supporting framework, into which asymmetric magnesium-based hydrogen generator (MHG) and BPNS are integrated. In PHO-MHG@BP, MHG enables controlled electron release and sustained microcurrent output through electrochemical reaction under OA microenvironment, while BPNS facilitates uniform electrical signals distribution throughout the cell and synergizes with Mg-derived H2 to scavenge ROS, thereby restoring the sensitivity of cellular electrophysiological channels. In addition, the system achieves pH-responsive cargo release via dynamic Schiff base bonds within the PHO network, precisely adapting to the acidic microenvironment of OA lesions. Physically, the MHG-BPNS coupling establishes a distributed in situ micro-galvanic network, converting localized random magnesium corrosion into a coordinated microcurrent field. Biologically, this platform is proposed to drive a ‘chemical resensitization and electrical activation’ loop: synergistic ROS scavenging restores the electro-responsiveness of L-VGCCs, thereby enabling subsequent bioelectrical signal transduction. These synergistic innovations provide a new theoretical foundation and engineering solution for the comprehensive treatment of OA.
2. Materials and methods
2.1. Materials
Magnesium powder was purchased from Tangshan Weihao Magnesium Powder Co., Ltd., and black phosphorus crystal powder was obtained from Sichuan KaqiKun Technology. Fresh Tibetan mini pig skin was provided by Guangzhou Huateng Biotechnology (License No. SYXK (Yue) 2024–0307). Polyvinylpyrrolidone (PVP, MW000), poly (lactic-co-glycolic acid) (PLGA), and PLGA (MW000, 50:50) were purchased from Innochem (Beijing, China), and hydroxypropyl chitosan, hyaluronic acid (MW: 1.5–2.5 MDa), ethyl acetate, sodium periodate, and 1-methyl-2-pyrrolidinone (NMP) were all acquired from Macklin (Shanghai, China). DMEM Eagle medium (DMEM), fetal bovine serum (FBS), trypsin-ethylenediaminetetraacetic acid (EDTA), phosphate-buffered saline (PBS), and penicillin-streptomycin (P/S) were purchased from Thermo Fisher (MA, USA). The C-28/I2 human immortalized chondrocyte cell line (HTX2308) and Raw264.7 mouse monocyte macrophage leukemia cells (HTX1760) were provided by Otwo Biotech Inc. (Shenzhen, China), and Sprague-Dawley (SD) rats were obtained from Zhuhai Bestest Biotechnology (license no. SCXK (Yue) 2020–051). All other chemical reagents used were of analytical grade.
2.2. Synthesis and characterization of MHG
Asymmetric MHGs were prepared using an embedding method according to our previous work [32,36]. Briefly, magnesium (Mg) microparticles were sieved (15 μm) and thoroughly washed with acetone to eliminate the surface oxide layer. Polyvinylpyrrolidone (PVP) was finely sprayed onto a glass plate, followed immediately by the application of an appropriate amount of Mg microparticles. A 1 wt% poly (lactic-co-glycolic acid) (PLGA) solution in ethyl acetate was carefully added dropwise to Mg microparticles. The resulting products were collected after the deposition had dried. The morphology was observed using scanning electron microscopy (SEM, Zeiss Gemini 300), and elemental mapping analysis was performed using energy-dispersive X-ray spectroscopy (EDS). The actual Mg content in the MHGs was determined using thermogravimetric analysis (TGA, TA Q500 HiRes).
2.3. Preparation of BPNS
BPNS were prepared via a liquid-phase exfoliation method [34,35,37]. Black phosphorus crystal powder (0.2 mg/mL) was dispersed in NMP and sonicated in an ice bath for 12 h (SCIENTZ-IID, Ningbo, China). The exfoliated dispersion was centrifuged at 4000 rpm to remove the sediment. Afterward, the supernatant was centrifuged at 13,500 rpm to collect the precipitate. The precipitate was washed with anhydrous ethanol and resuspended for storage. The final dispersion was stored in a sealed container at 4 °C. The particle size distribution was determined using a Malvern Zetasizer (Zetasizer Nano ZS90, UK). The morphology and lattice structure were characterized using scanning electron microscopy (SEM, Zeiss Gemini 300) and transmission electron microscopy (TEM., JEM-2100Plus).
2.4. Preparation of PHO-MHG@BP hydrogel
Oxidized hyaluronic acid (OHA) was synthesized using the sodium periodate oxidation method [38,39].HA (1.0 g, 2.5 mmol) was dissolved in 100 mL of double-distilled water. After dissolution, a solution of 0.32 g NaIO4 in 5 mL of double-distilled water was added dropwise, and the mixture was stirred in the dark at room temperature for 2 h. Subsequently, 0.5 mL of ethylene glycol was added to quench unreacted NaIO4. The reaction was stirred for an additional 1 h, followed by thorough dialysis against distilled water for 3 d using a dialysis bag with a molecular weight cutoff of 10,000, and finally freeze-dried to obtain OHA powder. The degree of oxidation was determined by hydroxylamine hydrochloride titration, and the chemical structure was characterized using Fourier-transform infrared spectroscopy (FTIR, BRUKER ALPHA II). Porcine acellular dermal matrix (PADM) was prepared according to previous studies [40].
PADM, HS, and OHA were separately dissolved in phosphate-buffered saline (PBS) at room temperature, and the pH was adjusted to 7.4. MHG and BPNS were dispersed in the solutions to prepare hydrogel precursors, yielding final concentrations of 2.5% PADM, 4% HS, 5% OHA, 2.0 mg/mL MHG (unless otherwise specified), and 200 μg/mL BPNS. Crosslinked hydrogels were formed by mixing the precursor solutions. X-ray diffraction (XRD) experiments were performed using a Bruker D2 diffractometer (Germany), X-ray photoelectron spectroscopy (XPS) was conducted using a Thermo Scientific Nexsa G2 instrument, and infrared spectra were acquired with a Fourier transform infrared (FTIR) spectrometer (BRUKER ALPHA II). Zeta potential was measured using a Malvern Zetasizer (Zetasizer Nano ZS90, UK).
2.5. Mechanical properties and injectability
The compressive properties of the hydrogels (8 mm diameter and 10 mm height) were evaluated using an electronic universal testing machine (DR-603A) at a compression rate of 1 mm/min. The injectability of the hydrogel was macroscopically assessed by extruding it through a 1 mL syringe. All experiments were independently repeated three times to ensure the reliability of the results.
2.6. Electrochemical properties
The electrical conductivity (σ) of the hydrogels was measured using a four-point probe method (Keithley 2400, USA). The resistance (R) was calculated from the current–voltage (I–V) curves, and the conductivity was determined using the formula σ = 2 × S × R (where S is the probe spacing). Cyclic voltammetry (CV, scan rate: 10 mV/s, potential range: −0.8 to 0.8 V) and electrochemical impedance spectroscopy (EIS, frequency range: 0.01 Hz to 100 kHz) analyses were performed using an electrochemical workstation (CHI660E, China). This three-electrode system employed hydrogel/ITO as the working electrode, Ag/AgCl as the reference electrode, a platinum plate as the counter electrode, and 0.1 M PBS as the electrolyte. To investigate the mechanism of electricity generation and corrosion kinetics of MHGs within the hydrogel network, open circuit potential (OCP) measurements and Tafel polarization curve tests were conducted. The potential variation over time (OCP-Time) was recorded after immersion in the electrolyte. Once the potential stabilized, Tafel polarization scanning was performed (scan rate: 1 mV/s), and the corrosion potential (Ecorr) and current density (icorr) were calculated using the Tafel extrapolation method. All experiments were independently repeated three times to ensure the reliability of the results.
Additionally, finite element modeling (FEM) simulations were performed using COMSOL Multiphysics software to visualize the distribution of microcurrents within the hydrogel. A 2D geometric model containing MHG particles and a BPNS conductive network was constructed, and the electric field intensity distribution within the hydrogel matrix was simulated and analyzed using the experimentally measured conductivity and electrochemical potential as material parameters and boundary conditions.
2.7. Rheological properties
The rheological properties of the hydrogels were evaluated at 25 °C using a rotational rheometer (MCR 302, Anton Paar, Austria). A parallel-plate geometry (25 mm diameter) was employed, with mineral oil applied to the sample periphery to prevent solvent evaporation. First, an amplitude sweep (strain: 0.1–1000%, 1 Hz) was conducted to determine the linear viscoelastic region (LVR). Subsequently, a frequency sweep (angular frequency: 0.1–100 rad/s) was performed at a fixed strain of 10% to monitor variations in the storage modulus (G′) and loss modulus (G″) to assess network structural stability. The self-healing properties were evaluated via step-strain measurements (alternating between 1% and 600% strain at 1 Hz), recording the rate and magnitude of G′ recovery following large deformation to reflect the network reconstruction capability. All tests were performed in triplicate, and the data were analyzed using RheoCompass software and expressed as mean ± SD.
2.8. Self-healing experiments
The self-healing performance of the hydrogels was evaluated via macroscopic morphological observations. Experiments were conducted at room temperature, where transparent PHO hydrogels and black PHO-MHG@BP hydrogels (containing BPNS and MHG) were prepared, labeled, and cut into cubic blocks with dimensions of approximately 10 mm × 10 mm × 5 mm. Subsequently, fresh cross-sections of identical or different hydrogel samples were brought into close contact to ensure interfacial alignment and allowed to stand undisturbed for 15 min without external stimuli to observe their self-healing behavior. The mechanical integrity and interfacial bonding strength of the healed samples were assessed using lifting, bending, and repeated stretching tests. All experiments were performed in triplicate under identical conditions to ensure reproducibility.
2.9. Controlled release experiments
H2 release was evaluated using a methylene blue-platinum (MB-Pt) probe, based on our previous studies with slight modifications [36]. In the presence of Pt nanoparticles, MB (with a characteristic absorption peak at 664 nm) reacts with H2 to form colorless leucomethyleneblue, according to the following reaction:
| MB (blue) + 2H+ + 2e− → leucoMB (colorless) |
Briefly, PHO-MHG@BP hydrogels (8 mm in diameter and 10 mm in height) loaded with varying amounts of MHG (0.5, 1.0, 2.0, and 4.0 mg/mL) were immersed in 10 mL of phosphate-buffered saline (PBS) at pH = 7.4 or pH = 6.0 and incubated at 37 °C. At predetermined time points, 1 mL of the release medium was collected and added to the MB-Pt probe solution (MB: 30 μM, Pt: 2 w/w%). The absorbance change at 664 nm was monitored using a UV-vis spectrophotometer (UV-2600i, Shimadzu, Japan) to quantify the H2 release based on a standard MB calibration curve. Mg2+ release was detected using a commercial magnesium assay kit (Abcam, USA). The experimental conditions were identical to those in the H2 release study, and the release medium was collected and analyzed according to the manufacturer's protocol. All experiments were independently repeated three times to ensure the reliability of the results.
To evaluate the pH variations induced by the electrochemical corrosion of MHG, the PHO-MHG@BP hydrogels were immersed in 10 mL of PBS with an initial pH of 7.4 or 6.0 and incubated at 37 °C. At predetermined time points (1, 3, 5, 7, and 14 days), the pH values of the supernatant were continuously recorded using a physiological pH meter.
2.10. Swelling and degradation assays
The initial weight (W0) of the crosslinked hydrogels and their weights after swelling in PBS at 37 °C for various time intervals (Wt). The swelling ratio was calculated using the following formula: Swelling ratio = (Wt - W0)/W0 × 100%. For the biodegradability assessment, freeze-dried hydrogels (initial weight: Wᵢ) were incubated with type II collagenase (0.5 U/mL) at 37 °C. At predetermined time points, the samples were retrieved, washed, lyophilized, and weighed (residual weight, Wᵣ). The degradation rate was determined using the following equation: degradation rate = (Wᵢ - Wᵣ)/Wᵢ × 100%. All experiments were independently repeated three times to ensure the reliability of the results.
2.11. Biocompatibility experiments
Biocompatibility was evaluated using a direct contact assay between the hydrogels and C-28/I2 chondrocytes. The hydrogels were placed in the wells of culture plates containing pre-adhered cells. After 1, 2, and 3 days of co-culture, the hydrogels were removed, and the cells were stained using a LIVE/DEAD staining kit (GLPbio, USA) and observed under an inverted fluorescence microscope (Nikon ECLIPSE Ti). Cell proliferation was assessed by measuring the absorbance at 450 nm using the Cell Counting Kit-8 (CCK-8, Servicebio, China). All experiments were independently repeated three times to ensure the reliability of the results.
2.12. Osteoarthritis cell model
C-28/I2 chondrocytes were treated with 10 ng/mL IL-1β (PeproTech, China) to induce OA-like inflammatory responses. C-28/I2 cells were seeded into 24-well plates. After adherence, IL-1β was added, and the composite hydrogels were simultaneously introduced for co-culture. The cells without IL-1β treatment served as the control group. All experiments were independently repeated three times to ensure the reliability of the results.
2.13. Detection of mRNA expression
Total RNA was extracted from C-28/I2 chondrocytes or Raw264.7 macrophages (Enzyvalley, China) and reverse-transcribed into cDNA (Enzyvalley, China). Real-time PCR (RT-PCR) was performed using a Bio-Rad CFX Opus 96 system. The specific primer sequences used for detection (Col2, Aggrecan, SOX9, MMP13, ADAMTS5, TNF-α, IL-6, IL-1β, and GAPDH) are listed in Table S2. Relative quantification was performed using the 2−ΔΔCT method. All experiments were independently repeated three times to ensure the reliability of the results.
2.14. Immunofluorescence staining
Treated C-28/I2 chondrocytes or Raw264.7 macrophages were seeded into confocal dishes for imaging. After fixation with 4% paraformaldehyde, permeabilization, and blocking with 1% BSA, the cells were incubated with primary antibodies (against Col2, MMP13, TNF-α, and IL-10, Servicebio, China) at 4 °C overnight. Subsequently, the cells were incubated with Cy3-conjugated secondary antibody (Servicebio, China) for 1 h. Nuclei and F-actin were counterstained with DAPI and FITC-conjugated phalloidin (Servicebio), respectively. Finally, images were acquired using a laser scanning confocal microscope (Zeiss LSM 980, Germany), and fluorescence quantification was performed using the ImageJ software. All experiments were independently repeated three times to ensure the reliability of the results.
2.15. In vitro antioxidant activity
C-28/I2 chondrocytes or RAW264.7 macrophages were exposed to 20 μM H2O2 for 12 h to induce oxidative stress and subsequently co-cultured with the hydrogels for 12 h. The cells were incubated with a 10 μM DCFH-DA probe (Servicebio, China) for 30 min, and intracellular ROS levels were analyzed using fluorescence microscopy and flow cytometry (FCM).
2.16. Detection of extracellular matrix in chondrocytes
C-28/I2 chondrocytes were initially seeded into 24-well plates. 24 h later, the composite hydrogels were introduced for co-culture, followed by the addition of H2O2 1 h later, and the culture was maintained for 7 days. Subsequently, the cells were fixed with 4% paraformaldehyde and stained with a Toluidine Blue O solution (Solarbio, China) and an Alcian Blue solution (pH 2.5, Solarbio, China). Extracellular matrix deposition was quantified using ImageJ software. The expression levels of COL2, Aggrecan, MMP13, and ADAMTS5 in chondrocytes were evaluated using RT-qPCR. All experiments were independently repeated three times to ensure the reliability of the results.
2.17. Western blot analysis
Total protein was extracted from the treated RAW264.7 macrophages. Protein concentration was quantified using a BCA protein assay kit (Beyotime, China). SDS-PAGE separated the proteins and subsequently transferred them onto polyvinylidene fluoride (PVDF) membranes. After blocking with 5% non-fat milk, the membranes were incubated with primary antibodies (against GAPDH and NF-κB p65, Abcam) overnight at 4 °C, followed by incubation with HRP-conjugated secondary antibodies (Abcam, USA) for 2 h at room temperature. The protein bands were visualized using a gel imaging system, and densitometric analysis was performed using the ImageJ software. All experiments were independently repeated three times to ensure the reliability of the results.
2.18. In vivo cartilage repair experiments
All animal procedures were conducted in strict accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (NIH) and were approved by the Animal Care and Use Committee of Southern Medical University. Fifty Sprague-Dawley (SD) rats were randomly allocated to five groups: sham operation, PBS control, PHO hydrogel, PHO-MHG, and PHO-MHG@BP. An OA rat model was established by destabilizing the medial meniscus (DMM) through transection of the medial meniscotibial ligament of the right knee. Treatments were initiated 1 week post-surgery via intra-articular injection (20 μL) every two weeks for a total of eight weeks. At 8 weeks post-surgery, knee joint pain associated with DMM was assessed using gait analysis. Subsequently, the rats were sacrificed, and their knee joints were harvested. The specimens were fixed in 4% paraformaldehyde for 24 h, decalcified, and embedded in paraffin. Radiographic evaluation was performed using micro-computed tomography (micro-CT, NMC-200, China). Histological assessment, including Hematoxylin and Eosin (H&E) staining, Safranin O/Fast Green (SO/FG) staining, and Alcian Blue staining, as well as immunohistochemistry (for Col2 and MMP13) and immunofluorescence (for TNF-α and IL-10), was conducted to assess cartilage degeneration. At 8 weeks post-surgery, venous blood samples were collected for comprehensive hematological analysis, including serum magnesium and inorganic phosphorus levels, as well as key biochemical indicators of liver and kidney function. Major organs were harvested for histopathological examination. Quantitative analysis was performed using ImageJ software, with three randomly selected regions per slide evaluated for H&E, SO/FG, and Alcian Blue staining, immunohistochemistry, and immunofluorescence analyses. All experiments were independently repeated five times to ensure reliable results.
2.19. RNA sequencing
Eight weeks post-surgery, rats in the control and PHO-MHG@BP groups were sacrificed, and their knee joints were isolated, flash-frozen in liquid nitrogen, and stored at −80 °C. Total RNA was extracted using TRIzol reagent (Invitrogen, CA, USA). RNA quantity and purity were assessed using a NanoDrop ND-1000 (NanoDrop, Wilmington, DE, USA), and RNA integrity was confirmed using an Agilent 2100 Bioanalyzer (Agilent, CA, USA) and agarose gel electrophoresis. Samples meeting the following criteria were processed for sequencing: RNA concentration > 50 ng/μL, RNA Integrity Number (RIN) > 7.0, OD260/280 ratio > 1.8, and total RNA amount > 1 μg. After mRNA enrichment using magnetic beads, sequencing libraries were prepared via end repair, adapter ligation, and PCR amplification. Subsequently, paired-end sequencing (150 bp) was performed on an Illumina NovaSeq™ 6000 platform (LC Bio Technology Co., Hangzhou, China), generating ≥ 6 GB of raw data per sample. Raw reads underwent quality control using fastp, were aligned to the reference genome (Homo sapiens, GRCh38) using HISAT2, and quantified via StringTie. Differentially expressed genes (DEGs) were identified using edgeR (screening criteria: p < 0.05 and |log2 fold change (FC) | ≥ 1). Finally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted using the DAVID tool.
To distinguish between the chemical effects of magnesium ions and the bioelectrical effects generated by material conductivity, an ion-equivalent control group was established by co-culturing C28/I2 cells with PHO-Mg(OH)2 hydrogels (releasing equivalent Mg2+) and PHO-MHG@BP hydrogels. The protein expression levels of CaMK2A, MMP13, and Col2 in both groups were verified by western blotting using antibodies purchased from Abcam. For the rescue experiment, nifedipine (1 μM, Abcam, USA) and the PHO-MHG@BP hydrogel were simultaneously added to the C28/I2 cells. All experiments were independently repeated three times to ensure the reliability of the results.
2.20. Statistical analysis
All sample sizes (n) were derived from at least three replicates (n ≥ 3). All data are presented as mean ± standard deviation (SD). Statistical comparisons were performed using the Student's t-test or one-way analysis of variance (ANOVA). Experimental data were analyzed using Origin 2024 and GraphPad Prism 10.1. All experiments were performed in triplicate unless otherwise specified. Statistical significance was set at p < 0.05. Significance levels are indicated as *p < 0.05, **p < 0.01, and ***p < 0.001.
3. Result and discussion
3.1. Synthesis of PHO-MHG@BP hydrogel
The preparation process of the PHO-MHG@BP hydrogel is illustrated in Fig. 1, which aims to construct a hydrogel system with dual electrochemical activities. Initially, magnesium-based electrochemical generators (MHGs) and black phosphorus nanosheets (BPNS) were synthesized via an embedding method and liquid-phase exfoliation, respectively (Fig. 2a), and subsequently integrated into a double-network hydrogel composed of PADM, HS, and OHA, thereby forming a three-dimensional electrochemical synergistic system characterized by mechanical stability and functional responsiveness. The MHGs were specifically engineered with an asymmetric coating structure to precisely modulate the electrochemical reaction interface [31,37]. The SEM image (Fig. 2b) revealed that the average particle size of the MHGs was 21.25 ± 3.69 μm, which was significantly larger than that of the unmodified Mg microparticles (14.49 ± 2.07 μm) (Fig. S1). Furthermore, the surface coating exhibited a unique asymmetric structure, with EDS mapping further confirming the asymmetric distribution of Mg, C, N, and O (Fig. S2). This suggests that local variations in the coating construct an anisotropic electrochemical reaction interface that effectively regulates localized electron flow and hydrogen gas release rates during corrosion, thereby maintaining a sustained and mild electrochemical energy output. Thermogravimetric analysis (TGA) demonstrated that the magnesium content of the MHGs reached 92.33 wt% (Fig. S3), indicating high purity and an ample reserve of reactive substrate, which provides a solid energy foundation for subsequent bioelectrical stimulation and therapeutic hydrogen release.
Fig. 1.

Schematic illustration of PHO-MHG@BP hydrogel for osteoarthritis therapy. The injectable Chemo-electroactive hydrogel system was established by integrating the MHG and BPNS into a self-healing hydrogel. The ROS scavenging and anti-inflammation, and micro-current remodel the inflammatory and bioelectrical microenvironment, promote chondrocytes proliferation for cartilage repair.
Fig. 2.

Synthesis and characteristics of PHO-MHG@BP hydrogel. a) Schematic illustration of the preparation of MHGs and BPNS. b) SEM images of MHGs and the corresponding elemental mapping of Mg, C, O, and N. c, d) TEM images of BPNS. e) SEM images of BPNS and the corresponding elemental mapping of P, C, O, and N. f) Macroscopic photographs and SEM images of HO, PHO, and PHO-MHG@BP hydrogels. g) XRD patterns of PHO, BPNS, MHGs, and PHO-MHG@BP hydrogels. h) FTIR spectra of PHO, BPNS, MHGs, and PHO-MHG@BP hydrogel. l) High-resolution XPS spectra of the PHO-MHG@BP hydrogel.
The preparation of BPNS is a critical step in achieving synergy between electrical conductivity and antioxidant functionality. BPNS obtained via liquid-phase exfoliation exhibited excellent dispersibility and morphological uniformity. The DLS results (Fig. S4) indicated that the BPNS had an average diameter of 244.8 ± 3.4 nm with a polydispersity index (PDI) of only 0.025, suggesting an extremely narrow particle size distribution. This characteristic is highly advantageous for constructing continuous and uniform electron transport channels within the hydrogel matrix. The SEM images (Fig. S5) further confirmed their uniform morphology. TEM analysis (Fig. 2c and d) clearly revealed the nanosheet structure of the BPNS, with a lattice fringe spacing of 0.25 nm, which is consistent with the structure of black phosphorus monolayers [41]. EDS spectra (Fig. 2e and Fig. S6) demonstrated that the BPNS were primarily composed of phosphorus (P) and oxygen (O), aligning with previous literature reports. In summary, the asymmetric structure of MHGs provides a controllable electrochemical energy source, while the BPNS, due to their high carrier mobility, establish efficient electron transport pathways and simultaneously endow the system with excellent antioxidant activity. The synergistic interaction of these components within the biomimetic double-network matrix enables the PHO-MHG@BP hydrogel to possess both sustained electrical stimulation capabilities and redox homeostasis regulation functions, thereby laying a dual structural and functional foundation for subsequent joint bioelectrical repair and alleviation of oxidative stress [42].
The hydrogel was designed to mimic the complex composition and biochemical microenvironment of the extracellular matrix (ECM) of natural joints. Among them, HA, a key component of cartilage ECM, was selected as the backbone material due to its excellent biocompatibility and cellular affinity [43]. We prepared OHA by using sodium periodate as an oxidant to specifically oxidize the vicinal hydroxyl groups on the HA sugar rings. FTIR spectra (Fig. S7) revealed a new characteristic peak for aldehyde groups at 1718 cm−1, confirming the success of the oxidation reaction. Hydroxylamine hydrochloride titration results indicated that the degree of oxidation of OHA was 34.2 ± 1.8%. Subsequently, the aldehyde groups of OHA reacted with the amino groups of HS via a Schiff base reaction to form dynamic reversible C=N bonds, constituting the first network. However, such single-network biopolymer hydrogels typically suffer from rapid structural fragmentation and lack sufficient biological complexity when subjected to the dynamic environment of the joint cavity. To overcome this intrinsic bottleneck, porcine acellular dermal matrix (PADM) was introduced as an indispensable core component to construct a double-network system. Rich in natural biological components such as collagen and glycosaminoglycans, PADM not only supplements natural ECM components to provide an optimal biomimetic niche for chondrocytes, but also interacts electrostatically via its negatively charged groups with positively charged HS, forming a second physical crosslinking network alongside the covalent network. The resulting PHO double-network hydrogel possesses both dynamic covalent bonds and electrostatic interactions, endowing it with excellent deformation recovery and structural stability. FTIR spectra (Fig. 2h) showed the appearance of a C=N stretching vibration peak at 1605 cm−1 in PHO, confirming the formation of dynamic Schiff base bonds. Zeta potential measurements (Fig. S8) showed that the surface potentials of PADM, HS, and PHO were −18.2 mV, 32.8 mV, and 9.8 mV, respectively. This trend of potential neutralization directly corroborates the significant electrostatic interaction between HS and PADM.
To achieve a balance between mechanical properties and gelation rate, the volume ratios of OHA, PADM, and HS were optimized and screened. Gelation time tests (Table S1) indicated that at an OHA: PADM: HS volume ratio of 4:1:8, excessive HS resulted in a stoichiometric imbalance, leading to the failure to form a stable network. Conversely, rheological analysis (Fig. S9) revealed that the storage modulus (G′) and loss modulus (G″) of the hydrogels significantly increased following the introduction of PADM, suggesting that electrostatic interactions effectively enhanced the structural integrity and energy storage capacity of the network. Moreover, hydrogels of all formulations exhibited excellent deformation reversibility and fatigue resistance during the step-strain cycles. Based on a comprehensive evaluation of gelation time and rheological properties, the optimal formulation for subsequent experiments was determined to be OHA: PADM: HS = 4:1:6 was ultimately determined as the optimal formulation for subsequent experiments. Based on this biomimetic matrix, we further synergistically introduced MHGs and BPNS to construct the PHO-MHG@BP hydrogel, which possesses both active electrical stimulation and immune microenvironment remodeling functions [34,35,37]. Macroscopic observation (Fig. 2f) revealed that HO, PHO, and PHO-MHG@BP all maintained a stable gel morphology in inverted vials, indicating the formation of a robust three-dimensional crosslinked network. The SEM results demonstrated that all three groups exhibited a three-dimensional porous network structure with uniform pore sizes. Notably, the introduction of PADM significantly increased the pore size, facilitates cell migration and mass exchange. In contrast, the incorporation of MHGs and BPNS only fine-tuned the network density without disrupting the overall pore structure, demonstrating excellent spatial compatibility. Further structural analysis verified the stable coexistence and interaction of the multiple components within the network. XRD patterns (Fig. 2g) showed that PHO-MHG@BP retained both the typical diffraction peaks of black phosphorus (34° and 56°, PDF#76-1957) and the characteristic diffraction features of magnesium (32°, 35°, and 37°, PDF#35-0821), indicating that the crystalline structure was preserved during gelation and that each active component maintained its original phase and function. In the FTIR spectra (Fig. 2h), in addition to the imine bond (C=N) at 1588 cm−1, characteristic absorption peaks attributed to C-O/P-O (1038–1056 cm−1) and Mg-O (460 cm−1) were observed, further confirming the effective integration and stable embedding of the functional components at the molecular scale.
XPS analysis (Fig. 2l and Fig. S10) definitively confirmed the elemental composition of the composite hydrogel. The peaks at 130.1 and 131.0 eV in the P 2p spectrum corresponded to elemental phosphorus, indicating that the bulk structure of the BPNS remained intact. In comparison, the presence of the characteristic Mg 1s peak (1304.0 eV) further verified the compositional consistency of the system. Collectively, these characterizations demonstrate the successful construction of the PHO-MHG@BP hydrogel system, featuring structural integrity, compositional homogeneity, and preservation of functional activity.
3.2. Physicochemical Characterizations of PHO-MHG@BP hydrogel
Excellent injectability is a crucial prerequisite for the in situ delivery of hydrogel into the articular cavity. Macroscopic observation demonstrated that the PHO-MHG@BP hydrogel could be smoothly extruded through a 1 mL syringe and rapidly recover a stable gel state at the injection site (Fig. 3g). Rheological frequency sweep results (Fig. 3a) showed that the storage modulus (G′) was consistently higher than the loss modulus (G″) across the entire frequency range, indicating that the system possesses a stable three-dimensional gel network structure. Amplitude sweep measurements (Fig. 3b) further confirmed that the PHO-MHG@BP hydrogel exhibits excellent shear-thinning behavior, fulfilling the requirements for injectability. To further analyze the load-bearing capacity of the hydrogels, compression tests were conducted (Fig. 3d and e). The results indicated that the compressive modulus of PHO-MHG@BP was approximately 93 kPa, significantly higher than that of PHO (72 kPa) and HO (56 kPa). Under high deformation conditions (80% compression), PHO and PHO-MHG@BP maintained their overall structural integrity, whereas HO collapsed at 67% compression. This indicates that the design of the double-network structure and the uniform dispersion of functional components significantly improved the compressive stability and energy dissipation capacity of the system. In summary, the double-network strategy combined with the physical embedding of MHG@BP endows the PHO-MHG@BP hydrogel with excellent structural stability and anti-fatigue properties. This enables it to function as a compliant viscoelastic buffer at the joint contact interface, ensuring the hydrogel resists wear and tear in the dynamic joint cavity while sustainably delivering chemo-electroactive therapeutic signals. Distinct from traditional brittle hydrogels, self-healing hydrogels can spontaneously repair following structural damage, ensuring long-term structural and functional integrity. Based on the reversible chemical nature of dynamic Schiff base bonds, PHO-MHG@BP exhibits superior self-healing capabilities. As shown in Fig. 3f, severed hydrogel samples (with or without MHG@BP) completed self-healing within 15 min at room temperature upon simple physical contact without external stimuli. The healed samples could withstand approximately 1.5-fold elongation and support four times their own weight without interfacial fracture, maintaining stable healing behavior even in a PBS environment (Fig. S11). Step-strain rheological analysis (Fig. 3c) further quantified this characteristic. During 1–600% strain cycles, the hydrogel achieved multiple rapid reversible transitions between high strain (G″ > G′, sol state) and low strain (G′ > G″, gel state), demonstrating excellent fatigue resistance and structural memory capabilities. Notably, the G′ value was slightly higher than the initial level after multiple cycles, which may be attributed to the flow state under high strain promoting the rapid reorganization of amino and aldehyde groups to form a denser crosslinked network. These characteristics, which combine plasticity, flexibility, and intelligent healing capabilities, ensure the structural integrity of the hydrogel under dynamic joint movements, making it an ideal candidate material for stable bioelectronic interfaces and sustained joint therapy.
Fig. 3.

Physicochemical properties of PHO and PHO-MHG@BP hydrogel. a) Macroscopic injectability of the PHO-MHG@BP hydrogel. b) Macroscopic self-healing of the PHO-MHG@BP hydrogel. c) Frequency sweep of PHO and PHO-MHG@BP hydrogels. d) Amplitude sweep of PHO and PHO-MHG@BP hydrogels. e) Stress-strain curves of HO, PHO, and PHO-MHG@BP hydrogels. f) Compressive moduli of the hydrogels. g) Step-strain tests of PHO and PHO-MHG@BP hydrogels. h) EIS spectra of PHO and PHO-MHG@BP hydrogels. i) CV curves of PHO, PHO-MHG, and PHO-MHG@BP hydrogels. j) OCP curves of PHO, PHO-MHG, and PHO-MHG@BP hydrogels over time. k) Tafel polarization curves of PHO-MHG and PHO-MHG@BP. l, m) COMSOL simulations of PHO-MHG and PHO-MHG@BP hydrogels. n) Cumulative H2 release curves of hydrogels with different MHG@BP contents over 7 days. o) Cumulative H2 release curves of the PHO-MHG@BP hydrogel in pH 7.4 and pH 6.0 solutions over 7 days. p) Cumulative H2 release curves of the PHO-MHG@BP hydrogel under pH-switching conditions (between pH 7.4 and pH 6.0). The data were quantified from three independent experiments and are presented as mean ± standard deviation. Statistical analysis was performed using one-way ANOVA followed by Tukey's post-hoc multiple comparison test (*p < 0.05, **p < 0.01, and ***p < 0.001).
To validate the efficacy and feasibility of the electrochemical synergistic mechanism based on metal corrosion principles, we systematically investigated the electrochemical properties and electron transport behavior of the PHO-MHG@BP hydrogel. Establishing a low-impedance and highly interconnected electron transport network is a crucial prerequisite for maintaining the stable propagation of electrical signals and facilitating the sustained diffusion of electrons from local sources to the deep matrix. Electrochemical impedance spectroscopy (EIS) results (Fig. 3h) showed a significant reduction in the semicircle diameter of the Nyquist plot for the PHO-MHG@BP hydrogel, indicating that the introduction of BPNS effectively decreased the interfacial charge transfer resistance, thereby constructing low-impedance channels within the hydrogel matrix that facilitate rapid electron transport [44,45].Quantitative results from the four-point probe method further revealed the multi-source conductive mechanism within the system (Fig. S12). The sole introduction of MHGs enhanced the ionic conductivity of the hydrogel (0.46 mS cm−1) via Mg2+. The subsequent incorporation of BPNS increased the overall conductivity to 0.63 mS cm−1, representing an approximately 2.5-fold enhancement compared to the PHO hydrogel (0.25 mS cm−1) and indicating the successful establishment of an ionic-electronic synergistic conductive mode. The larger oxidation peak area in the cyclic voltammetry curves (Fig. 3i) intuitively reflects the surge in the system's electrochemical activity, implying that under dynamic potential scanning, the BPNS network effectively increased the electrochemically active contact area, thereby greatly enhancing the interfacial electrontransfer and reaction kinetics. Furthermore, the successful illumination of an LED by connecting the PHO-MHG@BP hydrogel in series within a circuit (Fig. S13) provided intuitive verification, signaling the continuity of its conductive pathways.
To further elucidate the electricity generation mechanism of MHGs within the hydrogel network, open-circuit potential (OCP) tests were conducted (Fig. 3j). Unlike the PHO-BPNS hydrogel group containing only BPNS, which maintained a relatively positive inert potential at 0.1 V, the potential of the PHO-MHG@BP hydrogel group dropped rapidly upon immersion in the electrolyte and stabilized at −1.63 V within 10 s. This rapid potential response and stability were significantly superior to the hysteresis observed in the PHO-MHG hydrogel group, indicating that the conductive channels provided by BPNS significantly reduced the interfacial contact resistance, enabling efficient electron extraction from the magnesium anode. Tafel curves (Fig. 3k) further revealed the optimization of corrosion kinetics. Benefiting from the construction of conductive channels, the corrosion current density (icorr) of the PHO-MHG@BP hydrogel group significantly increased to 5.80 μA cm−2, which is approximately 1.85 times that of the PHO-MHG hydrogel group (3.14 μA cm−2). These results indicate that beyond serving as a passive conductive pathway, BPNS functions as an efficient heterogeneous cathode. By facilitating cathodic hydrogen evolution, it effectively mitigates polarization, accelerates magnesium anodic oxidation, and enhances electron output efficiency. To intuitively visualize the distribution of microcurrents in three-dimensional space, COMSOL finite element simulations were performed (Fig. 3l and m). The results showed that in the PHO-MHG group lacking conductive channels, high-intensity electric fields (>150 V m−1) were confined to a narrow region near the MHG interface and decayed rapidly, failing to establish an effective potential distribution across most of the matrix. In contrast, owing to the bridging effect of BPNS, the local electric fields within the PHO-MHG@BP hydrogel were effectively amplified and uniformly dispersed throughout the entire matrix, forming a widely interconnected electric field network. This indicates that such uniformly dispersed electric fields overcame signal attenuation, thereby providing the necessary electrophysiological stimulation for holistic cartilage regeneration in the damaged area. This spatially uniform electric field effectively overcame the geometric attenuation of signals, ensuring that the damaged cartilage tissue received sustained and comprehensive electrophysiological stimulation, thus laying a physical foundation for subsequent tissue regeneration. To further validate whether this excellent intrinsic conductivity translates into the successful remodeling of the bioelectrical microenvironment on actual biological tissues, we measured the ex vivo electrical impedance of articular cartilage using a four-point probe method. As depicted in Fig. S12, the impedance magnitude (|Z|) of the OA cartilage was significantly elevated to approximately 20.5 kΩ, nearly 7-fold higher than that of the healthy Sham group (∼2.8 kΩ). This macroscopic increase in electrical resistance confirmed that OA-induced ECM degradation essentially forms a high-impedance biophysical barrier. However, following the in situ application of the PHO-MHG@BP hydrogel, the local impedance of the OA cartilage was markedly reduced to ∼1.8 kΩ. This confirmed that the highly conductive BPNS and Mg components effectively bridged the tissue defect, reversed the OA-induced high impedance, and successfully established a low-resistance pathway on the actual pathological tissue.
In addition to its electricity-generating capability, the PHO-MHG@BP hydrogel achieved the concomitant release of therapeutic chemical agents during the electrochemical process. MHGs simultaneously generate electrons via anodic oxidation and induce a hydrogen evolution reaction at the cathode (2H2O + 2e− → H2 + 2OH−), thereby realizing the synchronous coupling of electricity generation and in situ antioxidative activity. As a widely recognized selective antioxidant molecule, H2 effectively scavenges cytotoxic hydroxyl radicals, protecting cells from oxidative damage [46,47]. Based on our previous studies, we quantitatively analyzed H2 release using a methylene blue-platinum (MB-Pt) probe method [36], as shown in Fig. S14. Bare Mg particles exhibited a sharp and transient burst release of hydrogen, whereas MHG@BP demonstrated a sustained and stable release profile. Further monitoring of the H2 release behavior of hydrogels containing varying amounts of MHG@BP (Fig. 3n) revealed an initial burst release of H2 within the first 0–12 h across all PHO-MHG@BP groups, followed by a sustained release phase. Notably, PHO-2.0MHG@BP and PHO-4.0MHG@BP exhibited sustained release characteristics capable of covering the early inflammatory stage of OA [48]. Simultaneously, the monitoring of Mg2+ release (Fig. S15) indicated that the PHO-2.0MHG@BP hydrogel group exhibited sustained release over 14 days, reaching a concentration of approximately 200 μg mL−1, a level previously reported to effectively promote chondrogenic differentiation and possess distinct chondroprotective effects [49]. Therefore, by balancing both the effects of electrical stimulation intensity and chemical regulation, we selected the MHG concentration of 2.0 mg/mL (denoted as the PHO-2.0MHG@BP group) as the optimal condition for subsequent experiments, aiming to achieve an effective equilibrium between the intensity of electrical stimulation and the concentration of therapeutic chemical agents.
Severe inflammatory reactions and a sharp decline in the pH value of synovial fluid typically accompany the progression of OA [50]. Based on this pathological characteristic, we hypothesized that an acidic environment would accelerate the cleavage of dynamic Schiff base bonds, thereby triggering the on-demand release of active components from the PHO-MHG@BP hydrogel [51]. Release experiments conducted in PBS under different pH conditions (pH = 6.0 and pH 7.4) confirmed this hypothesis. for both H2 and Mg2+, the release rates and cumulative amounts in the pH = 6.0 environment were significantly higher than those in the pH = 7.4 environment (Fig. 3o and Fig. S16). Optical microscopy observations (Fig. S17) revealed the generation of more macroscopic bubble clusters in the acidic environment. pH-switching experiments (Fig. 3p and Fig. S16) further demonstrated that when the environment was switched from pH 7.4 to pH 6.0, the release rates of H2 and Mg2+ exhibited an immediate response and accelerated. This pH-responsive release mechanism ensures that therapeutic agents can precisely target inflammatory regions, thereby maximizing therapeutic efficacy. Furthermore, to evaluate the risk of local alkalization induced by continuous OH− generation during Mg corrosion, the pH fluctuations of the release media were monitored over 14 days (Fig. S17). Under simulated physiological conditions, the local pH exhibited a marginal increase and stabilized at a safe plateau of ∼7.7. Conversely, in the acidic OA-like microenvironment, the PHO-MHG@BP hydrogel functioned as an active buffer, restoring and maintaining the pH at a physiological level (∼7.4) within 7 days. This robust pH homeostasis is attributed to the inherent buffering capacity of the PHO double-network. Consequently, this system effectively mitigates alkali-induced cytotoxicity while actively reversing the pathological acidic microenvironment, ensuring long-term in vivo biocompatibility.
Finally, excellent resistance to swelling is crucial for preventing pressure-induced tissue injury within the articular cavity. Swelling kinetics (Fig. S18) demonstrated that PHO-MHG@BP reached a swelling equilibrium of approximately 161% within 1 h in PBS and remained stable thereafter, exhibiting excellent resistance to swelling. In terms of biodegradability, type II collagenase (0.5 U mL−1, 37 °C) was employed to simulate the in vivo enzymatic degradation environment, and the results indicated that all hydrogels degraded gradually over time. By day 14, the degradation rate of the PHO group was approximately 81.2%, slightly higher than that of the PHO-MHG@BP group (72.5%) (Fig. S19), suggesting that the introduction of functional components enhanced network stability to a certain extent. Further subcutaneous implantation experiments in mice similarly revealed that 96.3% of the hydrogel degraded within 15 days, which is highly consistent with the in vitro results. In conclusion, the PHO-MHG@BP hydrogel network, constructed via dynamic covalent bonds, achieved intelligent sensing of and responsive release to inflammatory pH changes, while simultaneously possessing excellent swelling resistance and a biodegradation rate compatible with the tissue repair cycle. This synergistic optimization of multi-scale properties renders PHO-MHG@BP a comprehensive therapeutic platform featuring pH-sensitivity, in situ injectability, self-healing, and controlled release capabilities, thereby providing an efficient and controllable solution for precise intra-articular delivery in osteoarthritis.
3.3. Oxidative stress and inflammatory regulation effects of PHO-MHG@BP hydrogel
Excellent biocompatibility is a critical prerequisite for the long-term in vivo functionality of implantable biomaterials. To this end, we employed the C-28/I2 chondrocyte line to systematically evaluate the cytocompatibility of PHO-MHG and PHO-MHG@BP hydrogels. Initially, Live/Dead staining results intuitively exhibited the survival status of the cells (Fig. S20). After 3 days of co-culture with the hydrogels, nearly all cells displayed green fluorescence signals indicative of high viability, while red fluorescence signals representing dead cells were negligible within the field of view, suggesting the absence of acute cytotoxicity within the system. Further quantitative analysis using CCK-8 revealed that during the 3-day observation period, cells in all groups maintained a stable proliferation trend, with no significant difference in cell viability compared to the control group. This indicates that even with the introduction of electrochemically active components, the PHO matrix retained favorable cytocompatibility and nutrient permeability, imposing no inhibition on cell metabolism or proliferation. Furthermore, to evaluate the growth behavior of cells on the material surface, cytoskeletal fluorescence staining was performed using phalloidin (Fig. 4b). After 7 days of co-culture, C-28/I2 chondrocytes in all groups exhibited a uniformly spread spindle morphology, with intact filamentous actin (F-actin) structures arranged in an orderly fashion along the cell body, showing no signs of shrinkage or stress. Collectively, these results demonstrate that the PHO-MHG@BP hydrogel maintains excellent cytocompatibility and morphological stability while preserving its electrochemical functionality, thereby fully validating the biosafety of the system design. These findings establish a reliable biological foundation for subsequent intra-articular implantation and in vivo osteoarthritis repair experiments.
Fig. 4.

In vitro antioxidant and immunomodulatory effects of PHO-MHG@BP hydrogel. a) Schematic of in vitro antioxidant and immunomodulatory effects of the PHO-MHG@BP hydrogel. b) Phalloidin staining of C-28/I2 chondrocytes. c) Flow cytometry of intracellular ROS in C-28/I2 chondrocytes and Raw264.7 macrophages. d) Flow cytometry analysis of intracellular ROS levels in C-28/I2 chondrocytes. e) Alcian Blue staining of C-28/I2 chondrocytes. f) Toluidine Blue of C-28/I2 chondrocytes. g) Relative mRNA expression of Col2 and MMP13 in C-28/I2 under H2O2 treatment. h) Immunofluorescence quantification of IL-10 and TNF-α. i, j) Immunofluorescence images of IL-10 and TNF-α in Raw264.7 macrophages. k) Western blot analysis and relative quantification of p-p65 and p65. The data were quantified from three independent experiments and are presented as mean ± standard deviation. Statistical analysis was performed using one-way ANOVA followed by Tukey's post-hoc multiple comparison test (*p < 0.05, **p < 0.01, and ***p < 0.001). (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.)
During the progression of OA, persistent intra-articular oxidative stress is a core pathological factor that disrupts tissue repair homeostasis, drives inflammatory cascades, and ultimately leads to cartilage degradation [52,53]. Targeting this pathological feature, the PHO-MHG@BP hydrogel was designed as a system with high antioxidant efficiency, wherein MHGs serve as in situ chemical donors to continuously release reducing H2, while BPNS exerts a broad-spectrum free radical scavenging effect. To systematically evaluate the antioxidant efficacy of this system, we established an in vitro oxidative stress model using H2O2 [54] and detected intracellular ROS levels in C-28/I2 chondrocytes and Raw264.7 macrophages via a DCFH-DA probe. Results from flow cytometry (Fig. 4c) and fluorescence imaging (Fig. 4d and Fig. S21) consistently demonstrated that the PHO-MHG@BP hydrogel group significantly reduced the ROS fluorescence intensity in both cell types. Notably, the ROS levels in the PHO-MHG@BP hydrogel group were significantly lower than those in the PHO-MHG hydrogel group. This suggests that, in addition to the chemical scavenging effect of H2, the intrinsic antioxidant activity of BPNS further accelerated the reductive scavenging of free radicals, thereby achieving a more efficient antioxidant effect. Subsequently, we further investigated whether this superior antioxidant efficacy could translate into substantial protection for chondrocytes by examining their matrix synthesis function under an H2O2-induced oxidative injury environment. Alcian Blue (Fig. 4e) and Toluidine Blue staining (Fig. 4f) results demonstrated that, compared to the Blank group, the PHO-MHG@BP hydrogel group significantly enhanced the deposition of extracellular matrix. RT-qPCR analysis further quantified this protective effect (Fig. 4g and Fig. S22). Under oxidative stress conditions, the PHO-MHG@BP hydrogel group effectively maintained the expression of anabolic genes (Col2 and Aggrecan) in chondrocytes while simultaneously inhibiting the upregulation of catabolic markers (MMP13 and ADAMTS5). Collectively, these results demonstrate that the PHO-MHG@BP hydrogel can reconstruct the intracellular homeostatic environment by dynamically regulating the redox state, thereby fundamentally alleviating chondrocyte metabolic imbalance and matrix degradation induced by oxidative stress.
Given the close positive feedback loop between oxidative stress and inflammatory responses during the progression of OA, we further evaluated the regulatory effect of the PHO-MHG@BP hydrogel on the immunophenotype of Raw264.7 macrophages. Immunofluorescence (IF) analysis (Fig. 4h–j) revealed that following treatment with the PHO-MHG@BP hydrogel, the expression of the pro-inflammatory cytokine TNF-α in macrophages was significantly downregulated, while the expression of the anti-inflammatory cytokine IL-10 was markedly upregulated. RT-qPCR results further confirmed the decrease in the transcriptional levels of TNF-α, IL-6, and IL-1β, as well as the increase in IL-10 levels (Fig. S23). Finally, to elucidate the underlying molecular mechanism, we examined the activation status of the core inflammatory pathway, NF-κB. Western blot results (Fig. 4k) revealed that PHO-MHG@BP significantly reduced the phosphorylation of NF-κB p65, leading to a substantially lower p-p65/total p65 ratio. In summary, through its synergistic antioxidant functions, the PHO-MHG@BP hydrogel not only directly protects chondrocytes from oxidative damage but also achieves a cascading therapeutic effect, ranging from “oxidative stress scavenging” to “inflammatory microenvironment remodeling,” by blocking the ROS-mediated activation of the NF-κB signaling pathway.
3.4. In vitro cartilage regeneration induced by PHO-MHG@BP hydrogel
A severe disruption of ECM homeostasis frequently accompanies the pathogenesis of OA. Under a pro-inflammatory microenvironment (e.g., IL-1β stimulation), the metabolic equilibrium of chondrocytes is disrupted. The expression of key anabolic genes (Col2, Aggrecan, SOX9) is suppressed, while catabolic enzymes (MMP13, ADAMTS5) are drastically upregulated, leading to enzymatic degradation and loss of the ECM. To this end, an in vitro inflammation model was established using IL-1β-induced C-28/I2 chondrocytes to evaluate the ability of the PHO-MHG@BP hydrogel to restore ECM homeostasis and regulate chondrocyte metabolism under pathological conditions [[55], [56], [57]]. The RT-qPCR results revealed that IL-1β stimulation induced a pronounced degenerative phenotype in chondrocytes within the Blank group (Fig. 5b–f). In stark contrast, treatment with the PHO-MHG@BP hydrogel significantly reversed this pathological trend. Relative to the Blank group, the PHO-MHG@BP group exhibited a marked restoration in the gene expression levels of Col2, Aggrecan, and SOX9 (*p < 0.001), accompanied by the effective suppression of MMP13 and ADAMTS5 (*p < 0.001). Furthermore, the PHO-MHG@BP hydrogel demonstrated a significantly superior capacity for promoting anabolic gene expression compared to the PHO-MHG group (*p < 0.05, **p < 0.01, ***p < 0.001). This disparity strongly substantiates that the chemical signals released by MHG alone are insufficient for maximizing therapeutic efficacy. It highlights that the incorporation of BPNS is essential to establish a low-impedance conductive network. This hydrogel network could efficiently transmit the electron flow generated by the MHG to the cellular microenvironment to apply electrical stimulation, thereby further activating the anabolic potential of the cells and achieving cartilage regeneration driven by a dual electric-chemical mechanism.
Fig. 5.

In vitro chondrogenic effects of PHO-MHG@BP hydrogel. a) Schematic illustration of in vitro chondrogenesis promoted by the PHO-MHG@BP hydrogel. b-f) Relative mRNA expression levels of Col2, Aggrecan, SOX9, MMP13, and ADAMTS5. g, h) Immunofluorescence quantification of Col2 and MMP13. i, j) Immunofluorescence images of Col2 and MMP13 proteins in chondrocytes. The data were quantified from three independent experiments and are presented as mean ± standard deviation. Statistical analysis was performed using one-way ANOVA followed by Tukey's post-hoc multiple comparison test (*p < 0.05, **p < 0.01, and ***p < 0.001).
Further immunofluorescence (IF) staining analysis was performed on the core ECM component Col2 and the key degradation enzyme MMP13 (Fig. 5g–j). Under inflammatory stimulation, the PHO-MHG@BP group maintained high levels of Col2 protein deposition, with a fluorescence intensity significantly higher than that of the Blank group (p < 0.001), which were highly consistent with the RT-qPCR results. Conversely, the fluorescence intensity of the inflammatory marker MMP13 was significantly inhibited (p < 0.001). In summary, the PHO-MHG@BP hydrogel effectively suppressed inflammation-mediated matrix degradation and significantly restored the matrix synthesis capacity of chondrocytes. This bidirectional regulation of metabolic homeostasis suggests that this chemo-electroactive hydrogel system may exert synergistic mechanisms beyond remodeling the immune microenvironment that drive cartilage regeneration.
3.5. In vivo therapeutic effects of PHO-MHG@BP hydrogel
After confirming the superior anti-inflammatory, antioxidant, and cartilage-regenerating activities of the PHO-MHG@BP hydrogel by in vitro experiments, we established a DMM (Destabilization of the Medial Meniscus) rat OA model to further evaluate its in vivo therapeutic potential (Fig. 6a) [58,59]. First, to verify the in situ gelation performance of the PHO-MHG@BP hydrogel within the articular cavity, we mixed the pre-hydrogel solution or PBS solution with the MHG@BP solution prior to intra-articular injection, referencing previous studies [60]. Anatomical results (Fig. S24) revealed that the fluid in the articular cavity of the PBS group drained rapidly following capsulotomy, whereas the PHO-MHG@BP group formed a well-defined, uniformly textured gel mass within the cavity. This demonstrates excellent in situ gelation and local retention capabilities, ensuring the sustained action of functional components at the lesion site. Subsequently, DMM rats were randomly allocated into four groups: PBS, PHO, PHO-MHG, and PHO-MHG@BP. Treatments were initiated 1 week post-surgery via intra-articular injection and repeated every two weeks for an 8-week period. This dosing interval was matched with the hydrogel's ∼15-day in vivo degradation profile to ensure sustained therapeutic efficacy while preventing material accumulation within the joint cavity. After therapy, there were no obvious inflammatory lesions or tissue damage in the major visceral organs (heart, liver, spleen, lung, and kidney) in any group (Fig. S25). Moreover, the Routine blood analysis showed liver and kidney function, and serum magnesium and phosphorus concentrations were all within normal ranges, indicating that the excellent biosafety and systemic tolerance of PHO-MHG@BP hydrogel for long-term in vivo application.
Fig. 6.

In vivo therapeutic effects of PHO-MHG@BP hydrogel. a) Schematic illustration of the DMM surgery and treatment timeline. b) Representative 2D and 3D micro-CT images at 8 weeks. c-f) Quantitative analysis of tibial subchondral bone microstructure. g) H&E, TB, and SO/FG staining. h) OARSI scores. i) GAG content determined via TB and SO/FG staining. j) H&E staining of synovial tissues at 8 weeks. k) Synovial inflammation scores. l, m) Gait footprints and stride length statistics of rats in each group. The data were quantified from five independent experiments and are presented as mean ± standard deviation. Statistical analysis was performed using one-way ANOVA followed by Tukey's post-hoc multiple comparison test (*p < 0.05, **p < 0.01, and ***p < 0.001).
Subsequently, micro-computed tomography (micro-CT) analysis was performed on knee joint tissues harvested after 8 weeks of treatment (Fig. 6b). The results showed severe bone defects, bone tissue wear and deformation, and obvious osteophyte formation in the PBS group, whereas after PHO-MHG@BP hydrogel treatment, osteophytes were significantly reduced, and the tibial plateau surface became gradually smooth, closely approaching that of the Sham group. Quantitative analysis of bone microstructure parameters (Fig. 6c–f) showed that, compared to the PBS group, the bone volume fraction (BV/TV) in the PHO-MHG@BP group increased from 39.50 ± 4.14% to 58.04 ± 2.62%. trabecular number (Tb.N) increased from 0.645 ± 0.039 mm−1 to 1.118 ± 0.077 mm−1. trabecular thickness (Tb.Th) rose from 0.113 ± 0.008 mm to 0.161 ± 0.006 mm, and trabecular separation (Tb.Sp) decreased from 0.476 ± 0.021 mm−1 to 0.262 ± 0.028 mm−1. Notably, although the PHO-MHG hydrogel group releasing Mg2+ alone exhibited certain bone protective effects, all bone microstructural parameters of the PHO-MHG@BP group were significantly superior to those of the PHO-MHG hydrogel group. This indicates that the low-impedance channels constructed by BPNS successfully conducted microcurrents to the subchondral bone region, thereby more effectively maintaining the microstructural homeostasis of the subchondral bone through the synergistic action of electrical stimulation and Mg2+.
Histological staining further verified the in vivo cartilage protective efficacy of the PHO-MHG@BP hydrogel at the microscopic level. The results of H&E, Safranin O/Fast Green (SO/FG), and Toluidine Blue (TB) staining (Fig. 6g) showed that the cartilage surfaces in the PBS and PHO groups were rough, with obvious fissures in the deep structures and substantial proteoglycan loss (indicated by faint staining), corresponding to OARSI scores of 5.4 ± 0.61 and 5.0 ± 0.50, respectively. Although the introduction of MHG alleviated matrix degradation to some extent (OARSI score: 3.2 ± 0.57), its repair efficacy remained limited due to the lack of effective electron transport channels. In contrast, the PHO-MHG@BP group exhibited the optimal tissue repair characteristics, featuring an intact and smooth cartilage surface, orderly arranged chondrocytes, and uniform and intense matrix staining, with the OARSI score significantly reduced to 2.0 ± 0.71 (p < 0.001) (Fig. 6h). Quantitative analysis of glycosaminoglycan (GAG) further validated these results. As shown in Fig. 6i, the PHO-MHG@BP hydrogel group produced a nearly intact cartilage surface, exhibiting only slight loss of proteoglycans. Synovial thickness serves as a marker for knee joint inflammation. In diseased joints treated with PBS, PHO, and PHO-MHG, the synovial lining layer was significantly thickened, showing synovial hyperplasia accompanied by massive inflammatory cell infiltration (Fig. 6j), with inflammation scores increasing 4.8-fold compared to the Sham group (Fig. 6k). Conversely, the synovial structure treated with the PHO-MHG@BP hydrogel appeared nearly normal, with only mild inflammatory cell accumulation and an inflammation score increase of only 2.3-fold. These results indicate that this Chemo-electroactive hydrogel can effectively inhibit inflammatory responses and remodel the intra-articular microenvironment in vivo.
To evaluate the recovery of joint motor function, gait analysis was performed on OA rats. As shown in Fig. 6l and m, the gait of rats in the PBS group was disordered. In contrast, the footprints and stride length of the PHO-MHG@BP hydrogel group showed significant improvement, approaching the levels of the normal control group. To further quantitatively assess pain relief, von Frey and hot plate tests were conducted. Consistently, the PHO-MHG@BP group exhibited a significantly increased mechanical pain threshold and prolonged thermal reaction time compared to the PBS and PHO-MHG groups (Fig. S26). These findings collectively indicate that the PHO-MHG@BP hydrogel can significantly alleviate OA-induced motor dysfunction and pain responses. To comprehensively evaluate macroscopic joint recovery and the resolution of inflammation, knee joint diameters were continuously monitored over a 14-day period (Fig. S27). Following intra-articular injection, the PHO-MHG@BP group effectively suppressed the acute swelling peak at Day 1 and rapidly restored the joint diameter to a near-normal baseline level by Day 14. This significantly outperformed the PBS control, which exhibited persistent inflammatory joint swelling. Simultaneously, to exclude potential impacts of the injected bulk materials on the mechanical movement of the knee joint, the range of motion (ROM) of rats in each group was furtherly evaluated. The results showed there are no significant differences in ROM among different hydrogel injection groups (Fig. S28). Collectively, these macroscopic evaluations suggest that the PHO-MHG@BP hydrogel can rapidly alleviate inflammatory effusion and exert dual effects of cartilage repair and functional improvement, all without causing any additional mechanical obstruction to the joint cavity. The dysregulated ECM remodeling and chronic inflammation within articular cartilage are the core pathological factors driving the progression of OA. Therefore, regulating the dynamic balance between type II collagen and matrix metalloproteinases, and scavenging excessive inflammatory factors from the articular cavity, constitutes a key therapeutic strategy for ameliorating OA. Based on this, we further systematically validated the therapeutic mechanism of the PHO-MHG@BP hydrogel at the molecular level. Immunohistochemistry (IHC) staining results indicated (Fig. 7a) that the staining of Col2 in the PHO-MHG@BP hydrogel group was significantly intensified, demonstrating a marked enhancement in ECM synthetic activity, whereas the PBS and PHO hydrogel groups exhibited pale brown staining, suggesting a state of severe matrix degradation. Conversely, in the MMP13 immunohistochemical staining images, the brown-stained area in the PHO-MHG@BP hydrogel group was noticeably reduced, indicating that the PHO-MHG@BP hydrogel effectively inhibited the overactivation of matrix catabolic genes. The corresponding quantitative results (Fig. 7b and c) were consistent with the trends observed in the IHC images, further confirming the significant improvement in articular cartilage metabolic homeostasis by PHO-MHG@BP. To further evaluate its regulatory effect on the inflammatory microenvironment, we detected the expression levels of major inflammatory factors in the articular cavity via immunofluorescence staining. As shown in Fig. 7d–f, high-intensity TNF-α expression was observed in the articular cavity of the PBS group, indicating a state of high inflammation. Following treatment with PHO, PHO-MHG, and PHO-MHG@BP hydrogels, the fluorescence intensity of TNF-α decreased sequentially, with the PHO-MHG@BP hydrogel group exhibiting the most significant downward trend. Furthermore, PHO-MHG@BP successfully reversed the DMM-induced downregulation of IL-10 in OA rats, restoring its fluorescence intensity to a level comparable to that of the Sham group. These results indicate that the PHO-MHG@BP hydrogel, through an electrochemical synergistic strategy, effectively protects cartilage and simultaneously remodels the inflammatory microenvironment, thereby alleviating the progression of OA.
Fig. 7.

Immunohistochemistry and Immunofluorescence evaluation. a) Immunohistochemical staining of Col2 and MMP13 in rat knee joint tissues from each group. b, c) Expression levels of Col2 and MMP13 within different treatment groups. Immunofluorescence staining of IL-10 and TNF-α in rat knee joints from each group. d) Immunofluorescence staining of IL-10 in rat knee joints from each group. e) Immunofluorescence quantification of IL-10. f) Immunofluorescence staining of TNF-α in rat knee joints from each group. g) Immunofluorescence quantification of TNF-α. The data were quantified from five independent experiments and are presented as mean ± standard deviation. Statistical analysis was performed using one-way ANOVA followed by Tukey's post-hoc multiple comparison test (*p < 0.05, **p < 0.01, and ***p < 0.001).
3.6. Cartilage regeneration mechanisms regulated by PHO-MHG@BP hydrogel
To systematically elucidate the regulatory mechanism of the PHO-MHG@BP hydrogel on chondrocytes, RNA sequencing (RNA-seq) was performed on cartilage tissues from the PBS and PHO-MHG@BP groups after 8 weeks of treatment (Fig. 8a). Principal component analysis (PCA) (Fig. S29) revealed a significant separation in the gene expression profiles between the two groups. The correlation heatmap (Fig. 8b) further confirmed good intra-group reproducibility and significant inter-group differences. Volcano plot analysis (Fig. 8c) indicated that, compared to the control group, a total of 1657 differentially expressed genes (DEGs) were identified in the PHO-MHG@BP group, including 1058 upregulated and 599 downregulated genes. The heatmap of differential genes intuitively visualizes all DEGs between the two groups (Fig. 8d). Furtherly, GO and KEGG pathway enrichment analyses were performed to investigate the biological functions of these DEGs. GO enrichment analysis revealed that DEGs were significantly enriched in biological processes, including “cell adhesion”, “extracellular matrix organization”, “inflammatory response”, and “positive regulation of chondrocyte differentiation” (Fig. S30). KEGG pathway enrichment (Fig. 8e) further revealed significant enrichment in the “Calcium signaling pathway”, “ECM-receptor interaction”, “TNF signaling pathway”, and “IL-17 signaling pathway”. GSEA further validated this trend, showing that the PHO-MHG@BP hydrogel group significantly upregulated “extracellular matrix organization” (NES = 2.34) (Fig. 8f) and inhibited the aberrant upregulation of the “inflammatory response” (NES = −2.32) (Fig. 8g).
Fig. 8.

Mechanisms of Cartilage Regeneration Regulated by PHO-MHG@BP Hydrogel. a) Flowchart illustrating the extraction of knee cartilage tissues for RNA-seq. b) Correlation heatmap of cartilage samples from the PBS and PHO-MHG@BP hydrogel groups. c) Volcano plot of differentially expressed genes (DEGs). d) Heatmap of differentially expressed genes. e) Scatter plot of KEGG pathway enrichment analysis. f) GSEA plot of the “extracellular matrix organization” signaling pathway. g) GSEA plot of the “inflammatory response” signaling pathway. h) Flow cytometric detection of intracellular Ca2+ levels. i) Western blot bands of MMP13, p-CaMK2A, CaMK2A, Col2, and GAPDH. j) Quantitative analysis of the proportion of Ca2+-positive cells. k-m) Semi-quantitative analysis of p-CaMK2A, Col2, and MMP13 protein expression. n-q) Relative mRNA expression levels of Col2, SOX9, MMP13, and ADAMTS5 in C28/I2 cells in the presence or absence of Nifedipine. The data were quantified from three independent experiments and are presented as mean ± standard deviation. Statistical analysis was performed using one-way ANOVA followed by Tukey's post-hoc multiple comparison test (*p < 0.05, **p < 0.01, and ***p < 0.001).
Notably, the significant enrichment of the “Calcium signaling pathway” may imply the calcium channels have served as a critical hub connecting extracellular bioelectrical signals with intracellular biochemical reactions, as previous studies present. The calcium channels convert external electrical stimulation into intracellular second messenger cascades, thereby regulating the synthesis and metabolism of the ECM [61].Consequently, we hypothesized that the PHO-MHG@BP hydrogel could promote cartilage repair by regulating calcium flux. To this end, a series of experiments was conducted to verify the hypothesis throughout our research. First, the calcium fluorescent probe Fluo-4 AM was used to detect intracellular Ca2+ levels in C28/I2 cells following stimulation with the hydrogel. Flow cytometry results (Fig. 8h–j) showed that the cell population of the PHO-MHG@BP group in the FITC channel exhibited a rightward shift toward higher signal intensity compared with the Control group. Cells with a FITC fluorescence signal intensity greater than 1.9 × 105 were classified as positive. Quantitative results revealed that following PHO-MHG@BP hydrogel stimulation, the proportion of calcium-positive cells within the C28/I2 population significantly increased, confirming that the conductive PHO-MHG@BP hydrogel effectively induced intracellular calcium influx. The activation of calcium/calmodulin-dependent protein kinase II (CaMKII) is a core event in the calcium signaling pathway, and the phosphorylation of its α-subunit (CaMK2A) is considered a critical step in initiating the expression of genes related to ECM synthesis. To systematically decouple the contributions of accumulated magnesium ions, hydrogen gas, and electrical stimulation on calcium flux activation, two specific control groups were introduced. First, a dose-matched PHO-Mg(OH)2 hydrogel was evaluated. As shown in the comparative release profiles (Fig. S31), although its chemical dissolution exhibited a more rapid initial burst compared to the sustained electrochemical corrosion of PHO-MHG@BP, it provided a comparable cumulative Mg2+ dose at the evaluation time point. Second, the PHO-MHG hydrogel was included to provide identical dual-chemical signals (both H2 and Mg2+) but without the robust macroscopic electroactivity. WB results (Fig. 8i) demonstrated a hierarchical activation of the signaling pathway among the groups. While the PHO-MHG group exhibited a moderate increase in p-CaMK2A expression compared to the PHO-Mg(OH)2 baseline due to the synergistic antioxidant effect of H2, the expression of p-CaMK2A in the PHO-MHG@BP hydrogel group was significantly higher than that in both control groups. This robust electrical-driven activation was accompanied by the most profound upregulation of Col2 and downregulation of MMP13 (Fig. 8k–m). This indicates that electrochemical. synergistic stimulation significantly enhanced the activation efficiency of downstream anabolic signaling pathways. Finally, to interrogate multi-functional molecular target sensing of this electrical stimulation signal, the L-type voltage-gated calcium channel (L-VGCC) specific blocker Nifedipine was employed. RT-qPCR results (Fig. 8n–q) showed that after blocking this channel, even in the presence of the PHO-MHG@BP hydrogel, its promotional effects on anabolic genes (Col2, SOX9) and inhibitory effects on catabolic genes (MMP13, ADAMTS5) were reversed. Based on the above results, we propose the possible therapeutic mechanism: the PHO-MHG@BP hydrogel achieves multi-level biological regulation through an electrochemical coupling strategy. The released H2 and BPNS synergistically regulate cellular redox homeostasis, relieving the oxidative inhibition of L-VGCC. Simultaneously, the highly conductive channels constructed by BPNS effectively transmit microcurrents generated by MHG corrosion, inducing the opening of L-VGCC and promoting transmembrane Ca2+ influx, which further activates the CaMKII cascade, thereby driving ECM synthesis and inhibiting inflammatory degradation pathways. This process ultimately forms a self-powered, self-regulating cartilage regeneration signaling network, achieving a holistic therapeutic closed-loop that spans from local micro-electrical activation to cellular metabolic remodeling.
3.7. Potential mechanisms
The therapeutic effects of the PHO-MHG@BP hydrogel are proposed to derive from its unique electro-chemical dual-driven mechanism, which achieves the systemic activation of chondrocyte function and tissue regeneration through the synergistic regulation of long-term microcurrent output and the reconstruction of cellular redox homeostasis. In the body fluid environment, MHG serves as the anode, undergoing an oxidation reaction (Mg → Mg2+ + 2e−), while the water reduction reaction (2H2O + 2e− → H2 + 2OH−) occurs at the cathode surface. This process continuously outputs a flow of electrons and synchronously generates antioxidant H2, thereby achieving a self-driven energy supply. Electrons migrate uniformly within the hydrogel system through high-conductivity, low-impedance channels constructed by BPNS, forming a stable microcurrent electric field. This compensates for the impaired local bioelectrical signals under inflammatory states and restores the electrophysiological activity of the joint microenvironment. Simultaneously, the H2 generated accompanying MHG oxidation acts synergistically with BPNS to efficiently scavenge local ROS, significantly reducing cellular oxidative stress levels and remodeling cellular redox homeostasis. This “chemical resensitization” effect effectively relieves the oxidative inhibition of ROS on L-VGCC, enabling the channels to regain their responsiveness to electrical stimulation and laying a physiological foundation for subsequent signal transduction. Under electric field stimulation, the resensitized L-VGCCs are activated, inducing rapid intracellular Ca2+ influx and subsequently triggering the CaMKII cascade reaction. Activated CaMKII promotes the expression of anabolic marker genes (Col2, Aggrecan, SOX9) in chondrocytes while simultaneously inhibiting the aberrant upregulation of catabolic enzymes (MMP13, ADAMTS5), thereby driving ECM synthesis and tissue repair. In summary, the PHO-MHG@BP system achieves sustained self-regulation of the cartilage repair process through a bidirectional mechanism of “chemical resensitization & electrical stimulation activation,” providing a new paradigm for the precision treatment of inflammatory-degenerative joint diseases.
3.8. Study limitations
Despite the significant anti-inflammatory, antioxidant, and pro-regenerative activities exhibited by PHO-MHG@BP hydrogel in both in vivo and in vitro experiments, several limitations remain that necessitate in-depth exploration. First, distinct joint microenvironments may significantly influence the corrosion rate and current density distribution of MHGs. Future studies need to achieve a precise balance between discharge rate and tissue tolerance via surface nanocoating or intelligent responsive regulation strategies. Secondly, the highly complex and dynamic environment of the joint cavity—characterized by continuous synovial fluid washout, protein biofouling, and multidirectional mechanical loading—cannot be fully replicated by current in vitro static electrochemical evaluations or theoretical COMSOL finite element simulations. Although the robust biomimetic double-network matrix (PHO) acts as a physical shield to encapsulate the Mg-BPNS galvanic couples and maintain microcurrent stability in vivo, the precise degradation kinetics, real-time bioelectrical fluctuations, and the propagation efficiency of the electric field at the cartilage-bone interface under continuous joint wear remain challenging to capture. Although short-term experiments have demonstrated favorable biocompatibility, the long-term cumulative effects of magnesium ions, the in vivo metabolic pathways of BPNS oxidation/phosphorylation products, and their potential impacts on adjacent synovium and bone tissues require evaluation through long-term large animal studies. Notably, batch stability, consistency in large-scale preparation, and real-time quantitative monitoring of in vivo electrochemical output remain key technical bottlenecks that must be overcome for preclinical translation. Additionally, while the 8-week DMM rat model provides reliable prognostic indicators for early-to-mid stage cartilage repair, osteoarthritis is fundamentally a chronic disease. Future studies must evaluate the long-term therapeutic efficacy and biomechanical durability of the regenerated tissue over prolonged periods (e.g., 6–12 months) in large animal models. Overall, future work should focus on the precise regulation of electrochemical parameters, long-term biosafety validation, and verification in clinically relevant models to advance this platform toward a truly controllable, predictable, and clinically translatable self-powered joint repair system.
4. Conclusion
We innovatively developed the microenvironment-responsive, chemo-electroactive PHO-MHG@BP hydrogel with favorable injectability and self-healing capability. In vivo and in vitro experiments verified its robust ROS-scavenging, anti-inflammatory effects and capacity to protect articular cartilage, improve subchondral bone microstructure and restore joint function. In PHO-MHG@BP hydrogel, the asymmetric magnesium-based hydrogen generators (MHGs) serve as in situ H2 donors to restore redox homeostasis and electron sources for sustained current output; uniformly dispersed BPNS build low-impedance electron transport networks for deep microcurrent diffusion while synergizing with H2 to scavenge free radicals. Besides, the double-network structure improved the compressive modulus and structural integrity of the PHO-MHG@BP hydrogel, endowing it with excellent anti-fatigue properties to serve as a stable viscoelastic buffer. This ensures the material resists mechanical degradation and continuously releases chemo-electroactive signals under dynamic joint movements. Mechanistic studies demonstrated H2-BPNS synergistic ROS clearance could relieve L-VGCC oxidative inhibition, enabling microcurrent-activated Ca2+ influx and L-VGCC/CaMKII signaling cascade initiation to promote cartilage regeneration. Consequently, this system achieves synchronous pathological microenvironment remodeling and bioelectrical signal modulation, confirming the efficacy of integrated biochemical regulation and bio-electrophysiological restoration. Overall, this PHO-MHG@BP hydrogel not only provides a comprehensive therapeutic strategy for osteoarthritis but also facilitates the theoretical development of chemo-electroactive materials for tissue regeneration.
CRediT authorship contribution statement
Hongyu Zhong: Writing – original draft, Validation, Methodology, Investigation, Data curation. Qi He: Validation, Methodology, Formal analysis. Fang Qin: Writing – review & editing, Project administration. Yao Shu: Investigation, Formal analysis. Yijian Wang: Investigation, Formal analysis. Xiang Yang: Software, Formal analysis. Zhonghao Chen: Software, Methodology. Sheng Yao: Software, Methodology. Chuxuan Gui: Software, Methodology. Jing Xiang: Writing – review & editing, Funding acquisition. Lu Liu: Writing – review & editing, Project administration. Yun Chen: Writing – review & editing, Project administration. Yingfeng Tu: Writing – review & editing, Funding acquisition, Conceptualization. Kun Liu: Writing – review & editing, Supervision, Project administration, Funding acquisition, Conceptualization. Jinghui Yao: Writing – review & editing, Project administration, Funding acquisition.
Ethics approval and consent to participate
All experimental protocols (IACUC-LAC-20251202-001) were approved by the Animal Welfare and Ethics Committee of Nanfang Hospital, Southern Medical University, and the experimental procedures strictly adhered to the Guide for the Care and Use of Laboratory Animals and the ethical standards established by the National Research Council. The experimental animals were housed in a Specific Pathogen Free (SPF) environment under a 12 h light/dark cycle and allowed to acclimatize for 7 days with ad libitum access to standard rodent chow and water.
Declaration of competing interests
The authors declare no conflict of interest.
Acknowledgement
This work was supported by the National Natural Science Foundation of China (Grant No. 22678264, 52305023), National Key Research and Development Program of China (2022YFA1206900), Guangdong Basic and Applied Basic Research Foundation (2023A1515010220, 2024A1515011979), Guangzhou Basic and Applied Basic Research Foundation (Grant No. 2023A04J2268), Guangdong Medical Research Foundation (Grant No. A2024355), the President Foundation of The Third Affiliated Hospital of Southern Medical University(YM202507) are all provided the financial support to the authors.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.mtbio.2026.103604.
Contributor Information
Yun Chen, Email: chenyun88@smu.edu.cn.
Yingfeng Tu, Email: tuyingfeng1@smu.edu.cn.
Kun Liu, Email: liukun09@smu.edu.cn, liukun_gdou@163.com.
Jinghui Yao, Email: yaojinghui@smu.edu.cn.
Appendix. A. Supplementary data
The following is the Supplementary data to this article.
Data availability
Data will be made available on request.
References
- 1.Xie Y., Zinkle A., Chen L., Mohammadi M. Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nat. Rev. Rheumatol. 2020;16:547–564. doi: 10.1038/s41584-020-0469-2. [DOI] [PubMed] [Google Scholar]
- 2.Cho Y., Kim H., Yook G., Yong S., Kim S., Lee N., Kim Y., Kim J., Kim T.W., Chang M.J., Lee K.M., Chang C.B., Kang S., Kim J. Predisposal of interferon regulatory factor 1 deficiency to accumulate dna damage and promote osteoarthritis development in cartilage. Arthritis Rheumatol. 2024;76:882–893. doi: 10.1002/art.42815. Hoboken, N.J. [DOI] [PubMed] [Google Scholar]
- 3.Holzer L.A., Kraiger M., Talakic E., Fritz G.A., Avian A., Hofmeister A., Leithner A., Holzer G. Microstructural analysis of subchondral bone in knee osteoarthritis. Osteoporos. Int. : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2020;31:2037–2045. doi: 10.1007/s00198-020-05461-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hunter D.J., Bierma-Zeinstra S. Osteoarthritis. Lancet. 2019;393:1745–1759. doi: 10.1016/S0140-6736(19)30417-9. [DOI] [PubMed] [Google Scholar]
- 5.Loeser R.F., Goldring S.R., Scanzello C.R., Goldring M.B. Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum. 2012;64:1697–1707. doi: 10.1002/art.34453. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wang Y., Qin X., Feng Y., Zhang T., Wang X., Li J., Yin P., Yu Y., Liu C. Dual-gradient silk-based hydrogel for spatially targeted delivery and osteochondral regeneration. Adv. Mater. 2025;37 doi: 10.1002/adma.202420394. Deerfield Beach, Fla. [DOI] [PubMed] [Google Scholar]
- 7.Wirth T., Lafforgue P., Pham T. Nsaid: current limits to prescription. Jt. Bone Spine. 2024;91 doi: 10.1016/j.jbspin.2023.105685. [DOI] [PubMed] [Google Scholar]
- 8.Tryfonidou M.A., et al. “Old Drugs, New Tricks” – local controlled drug release systems for treatment of degenerative joint disease. Adv. Drug Deliv. Rev. 2020 doi: 10.1016/j.addr.2020.10.012. [DOI] [PubMed] [Google Scholar]
- 9.Kang Y., et al. Effect of Poly(Lactide-Co-Glycolide) nanoparticles on local retention of fluorescent material: an experimental study in mice. Korean J. Radiol. 2018 doi: 10.3348/kjr.2018.19.5.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Brown S., et al. Nanoparticle properties for delivery to cartilage: the implications of disease state, synovial fluid, and off-target uptake. Mol. Pharm. 2019 doi: 10.1021/acs.molpharmaceut.7b00484. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ni Z., et al. The exosome-like vesicles from osteoarthritic chondrocyte enhanced mature IL-1β production of macrophages and aggravated synovitis in osteoarthritis. Cell Death Dis. 2019 doi: 10.1038/s41419-019-1739-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Kalairaj M.S., Pradhan R., Saleem W., Smith M.M., Gaharwar A.K. Intra-articular injectable biomaterials for cartilage repair and regeneration. Adv. Healthcare Mater. 2024;13 doi: 10.1002/adhm.202303794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Atwal A., Dale T.P., Snow M., Forsyth N.R., Davoodi P. Injectable hydrogels: an emerging therapeutic strategy for cartilage regeneration. Adv. Colloid Interface Sci. 2023;321 doi: 10.1016/j.cis.2023.103030. [DOI] [PubMed] [Google Scholar]
- 14.Zhao Z., Wang P., Li Z., Wei X., Li S., Lu X., Dai S., Huang B., Man Z., Li W. Targeted lipid nanoparticles distributed in hydrogel treat osteoarthritis by modulating cholesterol metabolism and promoting endogenous cartilage regeneration. J. Nanobiotechnol. 2024;22:786. doi: 10.1186/s12951-024-02965-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Nasiri N., Hosseini S., Alini M., Khademhosseini A., Baghaban Eslaminejad M. Targeted cell delivery for articular cartilage regeneration and osteoarthritis treatment. Drug Discov. Today. 2019;24:2212–2224. doi: 10.1016/j.drudis.2019.07.010. [DOI] [PubMed] [Google Scholar]
- 16.Zou Z., Li H., Yu K., Ma K., Wang Q., Tang J., Liu G., Lim K., Hooper G., Woodfield T., Cui X., Zhang W., Tian K. The potential role of synovial cells in the progression and treatment of osteoarthritis. Explorations. 2023;3 doi: 10.1002/EXP.20220132. Beijing, China. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Yao Y., Cui X., Ding S., Wang K., Zhang M. Advances in electrical materials for bone and cartilage regeneration: developments, challenges, and perspectives. Adv. Sci. 2025;12 doi: 10.1002/advs.202411209. Weinheim, Baden-Wurttemberg, Germany. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Zhou R., Fu W., Vasylyev D., Waxman S.G., Liu C. Ion channels in osteoarthritis: emerging roles and potential targets. Nat. Rev. Rheumatol. 2024;20:545–564. doi: 10.1038/s41584-024-01146-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Biomaterials-Enabled Electrical Stimulation for Tissue Healing and Regeneration.
- 20.Chen L., Yang J., Cai Z., Huang Y., Xiao P., Wang J., Wang F., Huang W., Cui W., Hu N. Electroactive biomaterials regulate the electrophysiological microenvironment to promote bone and cartilage tissue regeneration. Adv. Funct. Mater. 2024;34 doi: 10.1002/adfm.202314079. n/a-n/a. [DOI] [Google Scholar]
- 21.Griffin M., Bayat A. Electrical stimulation in bone healing: critical analysis by evaluating levels of evidence. Eplasty. 2011;11:e34. [PMC free article] [PubMed] [Google Scholar]
- 22.Hiemer B., Krogull M., Bender T., Ziebart J., Krueger S., Bader R., Jonitz-Heincke A. Effect of electric stimulation on human chondrocytes and mesenchymal stem cells under normoxia and hypoxia. Mol. Med. Rep. 2018;18:2133–2141. doi: 10.3892/mmr.2018.9174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Zheng T., Pang Y., Zhang D., Wang Y., Zhang X., Leng H., Yu Y., Yang X., Cai Q. Integrated piezoelectric/conductive composite cryogel creates electroactive microenvironment for enhanced bone regeneration. Adv. Healthcare Mater. 2023;12 doi: 10.1002/adhm.202300927. [DOI] [PubMed] [Google Scholar]
- 24.Robinson W.H., Lepus C.M., Wang Q., Raghu H., Mao R., Lindstrom T.M., Sokolove J. Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis. Nat. Rev. Rheumatol. 2016;12:580–592. doi: 10.1038/nrrheum.2016.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Liu D., Wang X., Gao C., Zhang Z., Wang Q., Pei Y., Wang H., Tang Y., Li K., Yu Y., Cai Q., Zhang X. Biodegradable piezoelectric-conductive integrated hydrogel scaffold for repair of osteochondral defects. Adv. Mater. 2024;36 doi: 10.1002/adma.202409400. Deerfield Beach, Fla. [DOI] [PubMed] [Google Scholar]
- 26.Kovacevic S., Ali W., Martínez-Pa Eda E., Llorca J. Phase-field modeling of pitting and mechanically-assisted corrosion of mg alloys for biomedical applications. Acta Biomater. 2023;164:641–658. doi: 10.1016/j.actbio.2023.04.011. [DOI] [PubMed] [Google Scholar]
- 27.Kamrani S., Fleck C. Biodegradable magnesium alloys as temporary orthopaedic implants: a review, biometals : an international journal on the role of metal ions in biology. biochemistry, and medicine. 2019;32:185–193. doi: 10.1007/s10534-019-00170-y. [DOI] [PubMed] [Google Scholar]
- 28.Dieppe P.A., Lohmander L.S. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005;365:965–973. doi: 10.1016/S0140-6736(05)71086-2. London, England. [DOI] [PubMed] [Google Scholar]
- 29.Takahashi N., Rieneck K., van der Kraan P.M., van Beuningen H.M., Vitters E.L., Bendtzen K., van den Berg W.B. Elucidation of il-1/tgf-beta interactions in mouse chondrocyte cell line by genome-wide gene expression. Osteoarthr. Cartil. 2005;13:426–438. doi: 10.1016/j.joca.2004.12.010. [DOI] [PubMed] [Google Scholar]
- 30.Bolduc J.A., Collins J.A., Loeser R.F. Reactive oxygen species, aging and articular cartilage homeostasis. Free Radic. Biol. Med. 2019;132:73–82. doi: 10.1016/j.freeradbiomed.2018.08.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Dutta S., Roy M. Recent developments in engineered magnesium scaffolds for bone tissue engineering. ACS Biomater. Sci. Eng. 2023;9:3010–3031. doi: 10.1021/acsbiomaterials.2c01510. [DOI] [PubMed] [Google Scholar]
- 32.Zhang J., Ma X., Lin D., Shi H., Yuan Y., Tang W., Zhou H., Guo H., Qian J., Liu C. Magnesium modification of a calcium phosphate cement alters bone marrow stromal cell behavior via an integrin-mediated mechanism. Biomaterials. 2015;53:251–264. doi: 10.1016/j.biomaterials.2015.02.097. [DOI] [PubMed] [Google Scholar]
- 33.Li Y., Yue J., Yang C. Unraveling the role of mg(++) in osteoarthritis. Life Sci. 2016;147:24–29. doi: 10.1016/j.lfs.2016.01.029. [DOI] [PubMed] [Google Scholar]
- 34.Lu H., Wei J., Liu K., Li Z., Xu T., Yang D., Gao Q., Xiang H., Li G., Chen Y. Radical-scavenging and subchondral bone-regenerating nanomedicine for osteoarthritis treatment. ACS Nano. 2023;17:6131–6146. doi: 10.1021/acsnano.3c01789. [DOI] [PubMed] [Google Scholar]
- 35.Ran Y., Shi J., Ding Y., Li L., Lu D., Zeng Y., Qiu D., Yu J., Cai X., Pan Y. Black phosphorus nanosheets-loaded mussel-inspired hydrogel with wet adhesion, photothermal antimicrobial, and in situ remineralization capabilities for caries prevention. Adv. Sci. 2024;11 doi: 10.1002/advs.202409155. Weinheim, Baden-Wurttemberg, Germany. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Wang S., Liu K., Zhou Q., Xu C., Gao J., Wang Z., Wang F., Chen B., Ye Y., Ou J., Jiang J., Wilson D.A., Liu S., Peng F., Tu Y. Hydrogen‐powered microswimmers for precise and active hydrogen therapy towards acute ischemic stroke. Adv. Funct. Mater. 2021;31 doi: 10.1002/adfm.202009475. n/a-n/a. [DOI] [Google Scholar]
- 37.Liu M., Zhang W., Han S., Zhang D., Zhou X., Guo X., Chen H., Wang H., Jin L., Feng S., Wei Z. Multifunctional conductive and electrogenic hydrogel repaired spinal cord injury via immunoregulation and enhancement of neuronal differentiation. Adv. Mater. 2024;36 doi: 10.1002/adma.202313672. Weinheim. [DOI] [PubMed] [Google Scholar]
- 38.Li L., Wang N., Jin X., Deng R., Nie S., Sun L., Wu Q., Wei Y., Gong C. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention. Biomaterials. 2014;35:3903–3917. doi: 10.1016/j.biomaterials.2014.01.050. [DOI] [PubMed] [Google Scholar]
- 39.Su W., Chen Y., Lin F. Injectable oxidized hyaluronic acid/adipic acid dihydrazide hydrogel for nucleus pulposus regeneration. Acta Biomater. 2010;6:3044–3055. doi: 10.1016/j.actbio.2010.02.037. [DOI] [PubMed] [Google Scholar]
- 40.Zhou H., Chen L., Huang C., Jiang Z., Zhang H., Liu X., Zhu F., Wen Q., Shi P., Liu K., Yang L. Endogenous electric field coupling mxene sponge for diabetic wound management: haemostatic, antibacterial, and healing. J. Nanobiotechnol. 2024;22:530. doi: 10.1186/s12951-024-02799-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Shao J., Ruan C., Xie H., Chu P.K., Yu X. Photochemical activity of black phosphorus for near-infrared light controlled in situ biomineralization. Adv. Sci. 2020;7 doi: 10.1002/advs.202000439. Weinheim, Baden-Wurttemberg, Germany. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Jing X., Xu C., Su W., Ding Q., Ye B., Su Y., Yu K., Zeng L., Yang X., Qu Y., Chen K., Sun T., Luo Z., Guo X. Photosensitive and conductive hydrogel induced innerved bone regeneration for infected bone defect repair. Adv. Healthcare Mater. 2023;12 doi: 10.1002/adhm.202201349. [DOI] [PubMed] [Google Scholar]
- 43.Tan H., Chu C.R., Payne K.A., Marra K.G. Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials. 2009;30:2499–2506. doi: 10.1016/j.biomaterials.2008.12.080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zhang Y., Wu C., Xu Y., Chen Z., Li L., Chen J., Ning N., Guo Y., Yang Z., Hu X., Zhang J., Wang Y. Conductive hydrogels with hierarchical biofilm inhibition capability accelerate diabetic ulcer healing. Chem. Eng. J. 2023;463 doi: 10.1016/j.cej.2023.142457. [DOI] [Google Scholar]
- 45.Zhou Z., Zhao M., Fang H., Lin Z., Zheng X., Zhuo Y., Li Z., Zhou W., Wang X. Conductive hydrogel with responsive release of herbal-derived carbon dots for neurovascular reconstruction in diabetic critical limb ischemia. Chem. Eng. J. 2024;500 doi: 10.1016/j.cej.2024.157265. Lausanne, Switzerland : 1996. [DOI] [Google Scholar]
- 46.Chen L., Zhao M., Kang W., Yu L., Zhang C., Wu S., Song X., Zhao K., Liu P., Liu Q., Dai R., Zheng Z., Zhang R. Endogenous melanin and hydrogen-based specific activated theranostics nanoagents: a novel multi-treatment paradigm for rheumatoid arthritis. Adv. Sci. 2024;11 doi: 10.1002/advs.202401046. Weinheim, Baden-Wurttemberg, Germany. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhao P., Cai Z., Zhang X., Liu M., Xie F., Liu Z., Lu S., Ma X. Hydrogen attenuates inflammation by inducing early m2 macrophage polarization in skin wound healing. Pharmaceuticals. 2023;16:885. doi: 10.3390/ph16060885. Basel, Switzerland. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Hsia A.W., Jbeily E.H., Mendez M.E., Cunningham H.C., Biris K.K., Bang H., Lee C.A., Loots G.G., Christiansen B.A. Post-traumatic osteoarthritis progression is diminished by early mechanical unloading and anti-inflammatory treatment in mice. Osteoarthr. Cartil. 2021;29:1709–1719. doi: 10.1016/j.joca.2021.09.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Zheng L., Zhao S., Li Y., Xu J., Yan W., Guo B., Xu J., Jiang L., Zhang Y., Wei H., Jiang Q. Engineered mgo nanoparticles for cartilage-bone synergistic therapy. Sci. Adv. 2024;10 doi: 10.1126/sciadv.adk6084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Liao S., Jia S., Yue Y., Zeng H., Lin J., Liu P. Advancements in ph-responsive nanoparticles for osteoarthritis treatment: opportunities and challenges. Front. Bioeng. Biotechnol. 2024;12 doi: 10.3389/fbioe.2024.1426794. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Xu J., Liu Y., Hsu S. Hydrogels based on schiff base linkages for biomedical applications. Molecules. 2019 3005;24 doi: 10.3390/molecules24163005. Basel, Switzerland. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Chen D., Shen J., Zhao W., Wang T., Han L., Hamilton J.L., Im H. Osteoarthritis: toward a comprehensive understanding of pathological mechanism. Bone Res. 2017;5 doi: 10.1038/boneres.2016.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Charlier E., Relic B., Deroyer C., Malaise O., Neuville S., Collée J., Malaise M.G., De Seny D. Insights on molecular mechanisms of chondrocytes death in osteoarthritis. Int. J. Mol. Sci. 2016;17:2146. doi: 10.3390/ijms17122146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kang D., Shin J., Cho Y., Kim H., Gu Y., Kim H., You K.T., Chang M.J., Chang C.B., Kang S., Kim J., Kim V.N., Kim J. Stress-activated mir-204 governs senescent phenotypes of chondrocytes to promote osteoarthritis development. Sci. Transl. Med. 2019;11 doi: 10.1126/scitranslmed.aar6659. [DOI] [PubMed] [Google Scholar]
- 55.Xing L., Chen D., Boyce B.F. Mice deficient in nf-κb p50 and p52 or rank have defective growth plate formation and post-natal dwarfism. Bone Res. 2013;1:336–345. doi: 10.4248/BR201304004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Hu Q., Ecker M. Overview of mmp-13 as a promising target for the treatment of osteoarthritis. Int. J. Mol. Sci. 2021;22:1742. doi: 10.3390/ijms22041742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Wang T., Liu Y., Wang Y., Huang X., Zhao W., Zhao Z. Long non-coding rna xist promotes extracellular matrix degradation by functioning as a competing endogenous rna of mir-1277-5p in osteoarthritis. Int. J. Mol. Med. 2019;44:630–642. doi: 10.3892/ijmm.2019.4240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Suo J., Wang D., Wang J., Yin X., Hu X., Shao R., Chen S., Sun S., Feng J., Wang L., Feng H., Li Z., Hou W., Zhang L., Chen Y., Zheng X., Wang Z., Zou W. Targeting vgll4 maintains extracellular matrix homeostasis and mitigates osteoarthritis in a preclinical model. Nat. Commun. 2025;16:9315–9325. doi: 10.1038/s41467-025-64361-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Wang K., He W., Gong Z., Gao J., Gao T., Pan N., Wu D., Yang Y., Li Z., Zhao X., Ji M., Shen S. Zdhhc11-mediated palmitoylation alleviates chondrocyte senescence and serves as a therapeutic target for osteoarthritis. Nat. Aging. 2025;5:2228–2246. doi: 10.1038/s43587-025-00968-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Li G., Liu S., Chen Y., Zhao J., Xu H., Weng J., Yu F., Xiong A., Udduttula A., Wang D., Liu P., Chen Y., Zeng H. An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment. Nat. Commun. 2023;14:3159. doi: 10.1038/s41467-023-38597-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Liu Y., Weidle C., Mihaljević L., Watson J.L., Li Z., Yu L.T., Majumder S., Borst A.J., Carr K.D., Kibler R.D., Gamal El-Din T.M., Catterall W.A., Baker D. Bottom-up design of ca2+ channels from defined selectivity filter geometry. Nature. 2025;648:468–476. doi: 10.1038/s41586-025-09646-z. London. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data will be made available on request.
